Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia

Clinical Microbiology Reviews

Volumn 11, Issue 1, 1998, Pages 57-80

  Denton, Miles ^a   Kerr, Kevin G ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL GENE; BACTERIUM CARRIER; BACTERIUM CULTURE; BONE INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; ENDOCARDITIS; EYE INFECTION; GASTROINTESTINAL INFECTION; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTIOUS ARTHRITIS; METHODOLOGY; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PATIENT CARE; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SKIN INFECTION; SOFT TISSUE INFECTION; STENOTROPHOMONAS MALTOPHILIA; TAXONOMY; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0031983930     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.1.57     Document Type: Review

References (470)

1. Abussaud, M., and B. Mahawreh. 1994. Pseudomonas flora of citrus - plant nurseries in the Jordan valley. Pak. J. Bot. 26:235-240.
2. Acevedo, H. F., M. Slifkin, G. R. Pouchet, and M. Pardo. 1978. Immunohistological localisation of a chorio-gonadotrophin-like protein in bacteria isolated from cancer patients. Cancer 41:1217-1222.
3. A'Court, G., and C. S. Garrard. 1992. Nosocomial pneumonia in the intensive care unit: mechanisms and significance. Thorax 47:465-173.
4. Agger, W. A., T. H. Cogbill, H. Busch, Jr., J. Landercasper, and S. M. Callister. 1986. Wounds caused by corn-harvesting machines: an unusual source of infection due to gram-negative bacilli. Rev. Infect. Dis. 8:927-931.
5. Akova, M., G. Bonfiglio, and D. M. Livermore. 1991. Susceptibility to beta-lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 beta-lactamases. J. Med. Microbiol. 35:208-213.
6. Alonso, A., and J. L. Martinez. 1997. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41:1140-1142.
7. Anonymous. 1974. Pseudomonas in hatching eggs. Can. Poult. Rev. 49:18, 20, 22.
8. Aoun, M., P. Van der Auwera, C. Devleeshouwer, D. Daneau, N. Seraj, F. Meunier, and J. Gerain. 1992. Bacteraemia caused by non-aeruginosa Pseudomonas species in a cancer centre. J. Hosp. Infect. 22:307-316.
9. Arella, M., and M. Sylvestre. 1979. Production of an extracellular ribonuclease by Pseudomonas maltophilia. Can. J. Microbiol. 25:321-328.
10. Arpi, M., M. A. Victor, J. K. Moller, V. Jonsson, M. M. Hansen, N. A. Peterslund, and B. Bruun. 1994. Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand. J. Infect. Dis. 26:157-162.
11. Arpi, M., M. A. Victor, I. Mortensen, A. Gottschau, and B. Bruun. 1996. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods, APMIS 104:108-114.
12. Aucken, H. M., and T. L. Pitt. 1993. Lipopolysaccharide profile typing as a technique for comparative typing of gram-negative bacteria. J. Clin. Microbiol. 31:1286-1289.
13. Aznar, R., E. Alcaide, and E. Garay. 1992. Numerical taxonomy of pseudo-monads isolated from water sediment and eels. Syst. Appl. Microbiol. 14:235-246.
14. Babalova, M., J. Blahova, M. Lesicka-Hupkova, V. Kremery, and K. Kubonova. 1995. Transfer of ceftazidime and aztreonam resistance from nosocomial strains of Xanthomonas (Stenotrophomonas) maltophilia to a recipient strain of Pseudomonas aeruginosa ML-1008. Eur. J. Clin. Microbiol. Infect. Dis. 14:925-927.
15. Baddour, L. M., J. Meyer, and B. Henry. 1991. Polymicrobial infective endocarditis in the 1980s. Rev. Infect. Dis. 13:963-970.
16. Ballestero, S., I. Virseda, H. Escobar, L. Suarez, and F. Baquero. 1995. Stenotrophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 14:728-729.
17. Baltimore, R. S., and H. B. Jenson. 1990. Puncture wound osteocbondritis of the foot caused by Pseudomonas maltophilia. Pediatr. Infect. Dis. J. 9:143-144.
18. Bandin, I., P. Heinen, L. L. Brown, A. E. Toranzo. 1996. Comparison of different ELISA kits for detecting Renibacterium salmoninarum. Bull. Eur. Assoc. Fish Pathol. 16:19-22.
19. Barry, A. L., and R. E. Badal. 1982. Reliability of early identifications obtained with Enterobacteriaceae-Plus biochemical cards in the AutoMicrobic system. J. Clin. Microbiol. 16:257-265.
20. Barry, A. L., R. J. Fass, J. P. Anhalt, H. C. Neu, C. Thornsberry, R. C. Tilton, B. G. Painter, and J. A. Washington II. 1985. Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks. J. Clin. Microbiol. 21:880-883.
21. Baruchel, A., O. Hartmann, A. Andremont, and C. Tancrede. 1986. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside. J. Antimicrob. Chemother. 18(Suppl. E):167-173.
22. Bates, J. H., G. D. Campbell, A. L. Barren, G. A. McCracken, P. N. Morgan, E. B. Moses, and C. M. Davis. 1992. Microbial etiology of acute pneumonia in hospitalised patients. Chest 100:1005-1012.
23. Bauernfeind, A. 1993. Comparative in-vitro activities of the new quinolone, Bay y 3118, and Ciprofloxacin, sparfloxacin, tosufloxacin, CI 960 and CI 990. J. Antimicrob. Chemother. 31:505-522.
24. Bauernfeind, A., R. M. Bertele, K. Harms, G. Horl, R. Jungwirth, C. Petermuller, B. Przyklenk, and C. Weisslein-Pfister. 1987. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 15:270-277.
25. Belcour, B., D. Courtois, C. Ehret, and V. Petiard. 1993. Rapid production of irones by maturation of orris rhizomes by two bacterial strains. Phytopathology 34:1313-1315.
26. Bell, E. B. 1968. An immune-type agglutination of mouse spermatozoa by Pseudomonas maltophilia. J. Reprod. Fertil. 17:275-283.
27. Benezra, D., T. E. Kiehn, J. W. M. Gold, A. E. Brown, A. D. M. Turnbull, and D. Armstrong. 1988. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am, J. Med. 85: 495-498.
28. Ben Tovim, T., E. Eylan, A. Romano, and R. Stein. 1974. Gram-negative bacilli isolated from external eye infections. Infection 2:162-165.
29. Berbari, N., D. H. Johnson, and B. A. Cunha. 1993. Xanthomonas maltophilia peritonitis in a patient undergoing peritoneal dialysis. Heart Lung 22:282-283.
30. Berenbaum, M. C., V. L, Yu, and T. P. Felegie. 1983. Synergy with double and triple antibiotic combinations compared. J. Antimicrob. Chemother. 12:555-563.
31. Berg, G., and G. Balling. 1994. Bacterial antagonists to Verticillium dahliae. J. Phytopathol. 141:99-110.
32. Berg, G., P. Marten, and G. Balling. 1996. Stenotrophomonas maltophilia in the rhizosphere of oil-seed rape - occurrence, characterisation, and interaction with phytopathogenic fungi. Microbiol. Res. 151:19-27.
33. Bergogne-Berezin, E., D. Decre, and M. L. Joly-Guillou. 1993. Opportunistic nosocomial multiply-resistant bacterial infections - their treatment and prevention. J. Antimicrob. Chemother. 32(Suppl. A):39-47.
34. Biedenbach, D. J., L. D. Sutton, and R. N. Jones. 1995. Antimicrobial activity of CS-940, a new trifluorinated quinolone. Antimicrob. Agents Chemother. 39:2325-2330.
35. Bicknell, R., E. L. Emanuel, J. Gagnon, and S. G. Waley. 1985. The production and molecular properties of the zinc beta-lactamase of Pseudomonas maltophilia IID 1275. Biochem. J. 229:791-797.
36. Bingen, E. H., E. Denamur, N. Y. Lambert-Zechovsky, A. Bourdois, P. Mariani-Kurkdjian, J-P. Cezard, J. Navarro, and J. Elion. 1991. DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia. J. Clin. Microbiol. 29:1348-1350.
37. Binks, P. R., S. Nicklin, and N. C. Bruce. 1995. Degradation of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) by Stenotrophomonas maltophilia PB1. Appl. Environ. Microbiol. 61:1318-1322.
38. Bjerke, H. S., B. Leyerle, and M. M. Shabot. 1991. Impact of ICU infections on outcome from surgical care. Am. Surg. 57:798-802.
39. Blake, R. C., D. M. Choate, S. Bardhan, N. Revis, L. L. Barton, and T. G. Zocco. 1993. Chemical transformation of toxic metals by a Pseudomonas strain from a toxic waste site. Environ. Toxicol. Chem. 12:1365-1376.
40. Bland, L. A., M. J. Arduino, S. M. Aguero, H. S. Favero. 1989. Recovery of bacteria from reprocessed high flux dialyzers after bacterial contamination of the header spacers and O rings. ASAIO Trans. 35:314-316.
41. Blazevic, D. J. 1976. Current taxonomy and identification of non-fermentative gram-negative bacilli. Hum. Pathol. 7:265-275.
42. Boethling, R. S. 1975. Purification and properties of a serine protease from Pseudomonas maltophilia. J. Bacteriol. 121:933-941.
43. Boethling, R. S. 1975. Regulation of extracellular protease secretion in Pseudomonas maltophilia. J. Bacteriol. 123:954-961.
44. Bollet, C., A. Davin-Regli, and P. De Micco. 1995. A simple method for selective isolation of Stenotrophomonas maltophilia from environmental samples. Appl. Environ. Microbiol. 61:1653-1654.
45. Bonfiglio, G., and D. M. Livermore. 1991. Effect of media composition on the susceptibility of Xanthomonas maltophilia to beta-lactam antibiotics. J. Antimicrob. Chemother. 28:837-842.
46. Bonfiglio, G., and D. M. Livermore. 1994. Zinc ions and medium-dependent susceptibility to beta-lactams in Xanthomonas maltophilia. J. Antimicrob. Chemother. 33:181-183.
47. Bonfiglio, G., S. Stefani, and G. Nicoletti. 1995. Clinical isolate of a Xanthomonas maltophilia strain producing L1 deficient and L2 inducible β-lactamases. Chemotherapy 41:121-124.
48. Borowicz, J. J., S. Brishammar, and B. Gerhardson. 1995. A Xanthomonas maltophilia isolate tolerating up to 1% sodium azide in Tris/HCl buffer. World J. Microbiol. Biotechnol. 11:236-237.
49. Bottone, E. J., R. M. Madayag, and M. N. Qureshi. 1992. Acanthamoeba keratitis: synergy between amebic and bacterial co-contaminants in contact lens care systems as a prelude to infection. J. Clin. Microbiol. 30:2447-2450.
50. Bottone, E. J., A. A. Perez, R. F. Gordon, and M. N. Qureshi. 1994. Differential binding capacity and internalisation of bacterial substrates as factors in growth rate of Acanthamoeba spp. J. Med. Microbiol. 40:148-154.
51. Bottone, E. J., A. A. Perez II, and J. L. Oeser. 1994. Loofah sponges as reservoirs and vehicles in the transmission of potentially pathogenic bacterial species to human skin. J. Clin. Microbiol. 32:469-472.
52. Bottone, E. J., M. Reitano, J. M. Janda, K. Troy, and J. Cuttner. 1986. Pseudomonas maltophilia exoenzyme activity as a correlate in pathogenesis of ecthyma gangrenosum. J. Clin. Microbiol. 24:995-997.
53. Bradbury, J. F. 1984. Genus II. Xanthomonas, p. 199-210. In N. R. Krieg and 3. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. The Williams & Wilkins Co., Baltimore, Md.
54. British Thoracic Society Research Committee and the Public Health Laboratory Service. 1992. The aetiology, management, and outcome of severe community-acquired pneumonia on the intensive care unit. Respir. Med. 86:7-13.
55. Britt, A. J., N. C. Bruce, and C. R. Lowe, 1992. Identification of a cocaine esterase in a strain of Pseudomonas maltophilia. J. Bacteriol. 174:2087-2094.
56. Brooks, R. G., R. E. McCabe, K. L. Vosti, and J. S. Remington. 1985. Open trial of imipenem/cilastatin therapy for serious bacterial infections. Rev. Infect. Dis. 7(Suppl. 3):S496-S505.
57. Brown, L. L., T. P. T. Evelyn, G. K. Iwama, W. S. Nelson, and R. P. Levine. 1995. Bacterial species other than Renibacterium salmoninarum cross react with antisera against R. salmoninarum but are negative for the p57 gene of R. salmoninarum as detected by the polymerase chain reaction (PCR). Dis. Aquat. Org. 21:227-231.
58. Bryson, H. M., and R. N. Brogden. 1994. Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential. Drugs 47:506-535.
59. Burdge, D. R., M. A. Noble, M. E. Campbell, V. L. Krell, and D. P. Speert. 1995. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin. Infect. Dis. 20:445-458.
60. Calandra, G. B., K. R. Brown, L. C. Grad, V. I. Ahonkai, C. Wang, and M. A. Aziz. 1985. Review of adverse experience and tolerability in the first 2,516 patients treated with imipenem/cilastatin. Am. J. Med. 78(Suppl. A):73-78.
61. Cameron, J. L., W. A. Reese, V. S. Tayal, R. F. Clark, D. Kelso, E. R. Gonzalez, A. R. Garnett, and J. P. Ornato. 1986. Bacterial contamination of ambulance oxygen humidifier water reservoirs: a potential source of pulmonary infection. Ann. Emerg. Med. 15:1300-1302.
62. Canton, E., J. Peman, M. T. Jimenez, M. S. Ramon, and M. Gobernado. 1992. In vitro activity of sparfioxacin compared with those of five other quinolones. Antimicrob. Agents Chemother. 36:558-565.
63. Carmeli, Y., and M. Samore. 1996. Imipenem and ceftazidime treatment as risk factors for nosocomial acquisition of Stenotrophomonas (Xanthomonas) maltophilia: a (sic) historical cohort study. Infect. Control Hosp. Epidemiol. 17(Suppl.):P31.
64. Carr, H. S., T. J. Wladowski, and H. S. Rosenkranz. 1973. Silver sulfadiazine: in vitro antibacterial activity. Antimicrob. Agents Chemother. 4:585-587.
65. Carrell, D. J., M. E. Hammond, and W. D. Odell. 1993. Evidence for an autocrine/paracrine function of chorionic gonadotrophin in Xanthomonas maltophilia. Endocrinology 132:1085-1089.
66. Chan, E. L., and R. J. Zabransky. 1987. Determination of synergy by two methods with eight antimicrobial combinations against tobramycin-susceptible and trobramycin-resistant strains of Pseudomonas, Diagn. Microbiol. Infect. Dis. 6:157-164.
67. Chatelut, M., J. L. Dournes, G. Chabanon, and N. Marty. 1995. Epidemiological typing of Stenotrophomonas (Xanthomonas) maltophilia by PCR. J. Clin. Microbiol. 33:912-914.
68. Chen, S., E. M. Stroh, K. Wald, and A. Jalkh. 1992. Xanthomonas maltophilia endophthalmitis after implantation of sustained-release ganciclovir. Am. J. Ophthalmol. 15:772-773.
69. Cheng, A. F., M. K. W. Li, T. K. W. Ling, and G. L. French. 1987. Emergence of ofloxacin-resistant Citrobacter freundii and Pseudomonas maltophilia after ofloxacin therapy. J. Antimicrob. Chemother. 20:283-292.
70. Chester, V., and T. J. Cleary. 1980. Evaluation of the Minitek system for identification of nonfermentative and nonenteric fermentative gram-negative bacilli. J. Clin. Microbiol. 12:509-516.
71. Child, J., J. Andrews, F. Boswell, N. Brenwald, and R. Wise. 1995. The in vitro activity of CP99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents. J. Antimicrob. Chemother. 35: 869-876.
72. Chow, A. W., J. Wong, and K. H. Bartlett. 1988. Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia. Antimicrob. Agents Chemother. 32:782-784.
73. Clark, B. J., L. S. Harkins, F. A. Munro, and P. Devonshire. 1994. Microbial contamination of cases used for storing contact lenses. J. Infect. 28:293-302.
74. Cohn, R. C., M. Jacobs, and S. C. Aronoff. 1988. In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 32:395-396.
75. Cooke, P., J. Heritage, K. Kerr, P. M. Hawkey, and K. E. Newton. 1996. Different effects of zinc ions on in vitro susceptibilities of Stenotrophomonas maltophilia to imipenem and meropenem. Antimicrob. Agents Chemother. 40:2909-2910.
76. Corbel, M. J., F. A. Stuart, and R. A. Brewer. 1984. Observations on serological cross-reactions between smooth Brucella species and organisms of other genera. Dev. Biol. Stand. 56:341-348.
77. Craven, D. E., K. A. Steger, and T. W. Barber. 1991. Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s. Am. J. Med. 91(Suppl. 3B):44S-53S.
78. Crossley, K., and J. M. Matsen. 1973. Intravenous catheter-associated bacteremia: role of the diagnostic microbiology laboratory. Appl. Microbiol. 26:1006-1007.
79. Cullmann, W. 1991. Antibiotic susceptibility and outer membrane proteins of clinical Xanthomonas maltophilia isolates. Chemotherapy 37:246-250.
80. Cullmann, W., and W. Dick. 1990. Heterogeneity of beta-lactamase production in Pseudomonas maltophilia: a nosocomial pathogen. Chemotherapy 36:117-126.
81. Daley, C., I. Lim, J. Modra, and I. Wilkinson. 1990. Comparative evaluation of non-radiometric BACTEC and improved Oxoid Signal blood culture systems in a clinical laboratory. J. Clin. Microbiol. 28:1586-1590.
82. D'Amato, R. F., C. Thornsberry, C. N. Baker, and L. A. Kirven. 1975. Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin, polymyxin B, and carbenicillin. Antimicrob. Agents Chemother. 7:596-600.
83. Dapena, F., R. Selgas, A. Garcia-Perea, G. Del Peso, M. A. Bajo, M. J. Fernandez Reyes, C. Jimenez, and C. Sanchez. 1994. Clinical significance of exit site infections due to Xanthomonas in CAPD patients: a comparison with Pseudomonas infection. Nephrol. Dial. Transplant. 9:1774-1777.
84. Davin-Regli, A., C. Bollet, J. P. Auffray, P. Saux, and P. De Micco. 1996. Use of random amplified polymorphic DNA for epidemiological typing of Stenotrophomonas maltophilia. J. Hosp. Infect. 32:39-50.
85. Debette, J., and R. Blondeau. 1977. Characterisation de bacteries tellurique assimables a Pseudomonas maltophilia. Can. J. Microbiol. 23:1123-1127.
86. Debette, J., and R. Blondeau. 1980. Presence de Pseudomonas maltophilia dans la rhizosphere de quelques plantes cultivees. Can. J. Microbiol. 26: 460-463.
87. Debette, J., and G. Prensier. 1989. Immunoelectron microscopic demonstration of an esterase on the outer membrane of Xanthomonas maltophilia. Appl. Environ. Microbiol. 55:233-239.
88. Dembry, L. M., P. A. Farrell, D. R. Orcutt, L. A. Gerrity, and V. T. Andriole. 1997. In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest. J. Antimicrob. Chemother. 39(Suppl. B):35-42.
89. Demko, C., C. Doershuk, and R. Stern. 1995. Thirteen year experience with Xanthomonas maltophilia in patients with cystic fibrosis. Pediatr. Pulmon. Suppl. 12:244. (Abstract.)
90. Denis, F., A. Sow, M. David, J. P. Chivon, A. Samb, and I. D. Mar. 1977. Meningites a Pseudomonas maltophilia. A propos de deux cas. Med.Mal Infect. 7:228-231.
91. Denton, M. 1997. Stenotrophomonas maltophilia: an emerging problem in cystic fibrosis patients. Rev. Med. Microbiol. 8:15-19.
92. Denton, M., M. J. Hall, N. J. Todd, and J. M. Littlewood. 1995. A novel selective culture medium reveals a previously underestimated prevalence of Stenotrophomonas (Xanthomonas) maltophilia in a cystic fibrosis clinic, abstr. P14. In Abstracts of the 20th European Cystic Fibrosis Conference.
93. Denton, M., N. J. Todd, and J. M. Littlewood. 1996. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 15:402-405.
94. Denton, M., N. J. Todd, J. M. Littlewood, and P. M. Hawkey. 1996. Molecular typing of Stenotrophomonas maltophilia isolated from cystic fibrosis patients. J. Infect. 32:88.
95. Department of Health. 1993. Ice cubes: infection caused by Xanthomonas maltophilia. Hazard (93) 42. Medical Services Directorate, Department of Health, London, United Kingdom.
96. De Vos, P., and J. De Ley. 1983. Intra- and intergeneric similarities of Pseudomonas and Xanthomonas ribosomal ribonucleic acid cistrons. Int. J. Syst. Bacteriol. 33:487-509.
97. Diaz-Mitoma, F., G. K. M. Harding, T. J. Louie, M. Thomson, M. James, and A. R. Ronald. 1985. Prospective randomized comparison of imipenem/ cilastatin and cefotaxime for treatment of lung, soft tissue and renal infections. Rev. Infect. Dis. 7(Suppl. 3):S452-S457.
98. Di Fabio, J. L., M. B. Perry, and D. R. Bundle. 1987. Analysis of the lipopolysaccharide of Pseudomonas maltophilia 555. Biochem. Cell Biol. 65:968-977.
99. Dirksen, M. S. C., R. G. F. Wintermans, J. B. J. Boerema, and J. S. F. Gimbrere. 1986. Imipenem as monotherapy in the treatment of intensive care patients with severe infections. J. Antimicrob. Chemother. 18(Suppl. E): 145-151.
100. Dismukes, W. E., A. W. Karchmer, M. J. Buckley, W. G. Austen, and M. N. Swartz. 1973. Prosthetic valve endocarditis. Circulation 48:365-377.
101. Dobbins, J. J., G. S. Johnson, C. M. Kunin, and W. C. De Vries. 1988. Post-mortem microbiological findings of two artificial heart recipients. JAMA 259:865-869.
102. Doerr, C. A., G. J. Demmler, J. A. Garcia-Prats, and M. L. Brandt. 1994. Solitary pyogenic liver abscess in neonates: report of three cases and review of the literature. Pediatr. Infect. Dis. J. 13:64-69.
103. Donzis, P. B., B. J. Mondino, B. A. Weissman, and D. A. Bruckner. 1987. Microbial contamination of contact lens care systems. Am. J. Ophthalmol. 104:325-333.
104. Drancourt, M., C. Bollet, and D. Raoult. 1997. Stenotrophomonas africana sp. nov., an opportunistic human pathogen in Africa. Int. J. Syst. Bacteriol. 47:160-163.
105. Draper, C. S., R. D. Walker, and H. E. Lawler. 1981. Patterns of oral bacterial infection in captive snakes. J. Am. Vet. Med. Assoc. 179:1223-1226.
106. Dufresne J., G. Vezina, and R. C. Levesque. 1988. Molecular cloning and expression of the imipenem-hydrolysing beta-lactamase gene from Pseudomonas maltophilia in Escherichia coli. Rev. Infect. Dis. 10:806-817.
107. Durbec, O., J. Albanese, M. F. Brunel, F. Soula, and C. Granthil. 1989. Septicemie foudroyante a Pseudomonas maltophilia au cours d'un traitement par imipeneme et amikacine. Presse Med. 18:227-228.
108. Dutkiewicz, J., W. G. Sorenson, D. M. Lewis, and S. A. Olenchock. 1992. Levels of bacteria, fungi, and endotoxin in stored timber. Int. J. Biodeter. Biodeg. 30:29-41.
109. Dyte, P. H., and J. A. Gillians. 1977. Pseudomonas maltophilia infection in an abattoir worker. Med. J. Aust. 1:444-445.
110. Edinger, R., R. R. Courtney, and G. E. Hollick. 1994. Evaluation of the Pasco gram-negative non-fermenter identification system. Diagn. Microbiol. Infect. Dis. 19:61-63.
111. Edwards, J. R., P. J. Turner, C. Wannop, E. S. Withnell, A. J. Grindley, and K. Nairn. 1989. In vitro anti-bacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I. Antimicrob. Agents Chemother. 33:215-222.
112. Elad, Y., J. Koelh, and N. J. Fokkema. 1994. Control of infection and sporulation of Botrytis cinerea on bean and tomato by saprophytic bacteria and fungi. Eur. J. Plant Pathol. 100:315-336.
113. Elkhaili, H., D. Pompei, L. Linger, N. Kamili, H. Monteil, and F. Jehl. 1996. Cinetique de bactericidie de cefepime et cefpirome seuls ou associés a la gentamicine, amikacine ou ciprofloxacine sur Acinetobacter baumanii, Stenotrophomonas maltophilia et Enterobacter cloacae hyperproducteur de cephalosporinase. Pathol. Biol. 44:367-373.
114. EI-Sweify, M., and M. F. F. Aly. 1996. Polymerase chain reaction-based ribotyping of Pseudomonas maltophilia: a potential epidemiological marker. Infect. Control Hosp. Epidemiol. 17:45.
115. Elting, L. S., and G. P. Bodey. 1990. Septicaemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine 69:296-306.
116. Elting, L. S., N. Khardori, G. P. Bodey, and V. Fainstein. 1990. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect. Control Hosp. Epidemiol. 11:134-138.
117. Fabe, C., P. Rodriguez, P. Cony-Malchoul, P. Parneix, C. Bebear, and J. Mougein. 1996. Typage moleculaire par electrophorese en champ pulse de souches de Stenotrophomonas maltophilia isolees dans un service d'hematologie. Pathol. Biol. 44:435-451.
118. Fang, F. C., and N. E. Madinger. 1996. Resistant nosocomial gram-negative bacillary pathogens: Acinetobacter baumanii, Xanthomonas maltophilia, and Pseudomonas cepacia. Curr. Top. Infect. Dis. Clin. Microbiol. 116:52-83.
119. Fang, G.-D., M. Fine, J. Orloff, D. Arisumi, V. L. Yu, W. Kapoor, J. T. Grayston, S. P. Wang, R. Kohler, R. R. Muder, V. C. Yee, J. D. Rihs, and R. M. Vickers. 1990. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multi-center study of 359 cases. Medicine 69:307-316.
120. Farr, B. M., D. L. Karser, B. D. W. Harrison, and C. K. Connolly. 1989. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. Thorax 44:1031-1035.
121. Fass, R. J., J. Barnishan, M. C. Solomon, and L. W. Ayers. In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against non-fermentative gram-negative bacilli. Antimicrob. Agents Chemother. 40:1412-1418.
122. Fass, R. J., and R. B. Prior. 1989. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Antimicrob. Agents Chemother. 33:1268-1272.
123. Feeley, T. W., G. C. Du Moulin, J. Hedley-White, L. S. Bushnell, J. P. Gilbert, and D. S. Feingold. 1975. Aerosol polymyxin and pneumonia in seriously ill patients. N. Engl. J. Med. 293:471-475.
124. Felegie, T. P., V. L. Yu, L. W. Rumans, and R. B. Yee. 1979. Susceptibility of Pseudomonas maltophilia to antimicrobial agents singly and in combination. Antimicrob. Agents Chemother. 16:833-837.
125. Felici, A., and G. Amicosante. 1995. Kinetic analysis of extension of substrate specificity with Xanthomonas maltophilia, Aeromonas hydrophila, and Bacillus cereus metallo-beta-lactamases. Antimicrob. Agents Chemother. 39:192-199.
126. Felici, A., G. Amicosante, A. Oratore, R. Strom, P. Ledent, B. Joris, L. Fanuel, and J.-M. Frere, 1993. An overview of the kinetic parameters of class B beta-lactamases. Biochem. J. 291:151-155.
127. Fenton, J. J., H. H. Harsch, and D. Klein. 1973. Production of volatile nitrogenous compounds from the degradation of streptomycin by Pseudomonas maltophilia. J. Bacteriol. 116:1267-1272.
128. Fischer, J. J. 1973. Pseudomonas maltophilia endocarditis after replacement of the mitral valve: a case study. J. Infect. Dis. 128(Suppl.):S771-S773.
129. Fisher, M. C., S. S. Long, E. M. Roberts, J. M. Dunn, and R. K. Balsara. 1981. Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA 246:1571-1574.
130. Flaherty, J. P., S. Garcia-Houchins, R. Chudy, and P. M. Arnow. 1993. An outbreak of gram-negative bacteremia traced to contaminated O-rings in reprocessed dialyzers. Ann. Intern. Med. 119:1072-1078.
131. Ford, A. S., A. L. Baltch, R. P. Smith, and W. Ritz. 1993. In vitro susceptibilities of Pseudomonas aeruginosa and Pseudomonas spp. to the new fluoroquinolone clinafloxacin and PD 131628 and nine other antimicrobial agents. J. Antimicrob. Chemother. 31:523-532.
132. Franzetti, F., M. Cernuschi, R. Esposito, and M. Moroni. 1992. Pseudomonas infections in patients with AIDS and AIDS-related complex. J. Intern. Med. 231:437-443.
133. Frederiksen, B., N. Hoiby, and C. Koch. 1995. Stenotrophomonas (Xanthomonas) maltophilia at the Danish Cystic Fibrosis Centre 1974-1993. Pediatr. Pulmon. Suppl. 12:287. (Abstract.)
134. Fritsche, D., R. Lutticken, and H. Bohmer. Pseudomonas maltophilia als Erreger menschlicher Infektionen. Zentralbl. Bakteriol. Mikrobiol. Hyg. Abt. 1 Orig. A 229:89-97.
135. Fritz, M. E., P. I. Eke, J. Malmquist, and R. Hardwick. 1996. Clinical and microbiological observations of early polytetrafluoroethylene membrane exposure in guided bone regeneration. Case reports in primates. J. Periodontol. 67:245-249.
136. Fuchs, P. C., A. L. Barry, and M. A. Pfaller. 1994. Antibacterial activity of PD 131628 and proposed disc diffusion susceptibility test criteria. J. Antimicrob. Chemother. 33:1147-1154.
137. Fujita, J., I. Yamadori, G. Xu, S. Hojo, K. Negayama, H. Miyawaki, Y. Yamaji, and J. Takahara. 1996. Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir. Med. 90: 35-38.
138. Ganadu, M., G. L. Mura, A. M. Campus, G. L. Cherchi, V. Fanelli, L. Calvisi, G. Canu, and G. B. Cherchi. 1996. Relapsing pyrogenic reactions due to Xanthomonas maltophilia in a dialysis patient with a long-term central venous catheter. Nephrol. Dial. Transplant. 11:197-198.
139. Garau, J., R. Martin, E. Bouza, J. Romero, J. A. Garcia-Rodriguez, E. Perea, F. Martinez Luengas, M. Gobernado, and R. Montero. 1986. Imipenem in the treatment of severe bacterial infections in seriously ill patients. J. Antimicrob. Chemother. 18(Suppl. E):131-140.
140. Garcia, A., M. F. Sierra, and J. Friberg. 1981. Survival of bacteria after freezing of human semen in liquid nitrogen. Fertil. Steril. 35:549-551.
141. Garcia-Rodriguez, J. A., M. J. Fresnadillo, M. I. Garcia Garcia, E. Garcia Sanchez, J. E. Garcia Sanchez, I. Trujillano, and the Spanish Study Group on Quinolone Resistance. 1995. Multicenter Spanish study of ciprofloxacin susceptibility in gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 14:456-459.
142. Garcia-Rodriguez, J. A., J. E. Garcia Sanchez, M. I. Garcia Garcia, E. Garcia Sanchez, and J. L. Munoz Bellido. 1991. Antibiotic susceptibility profile of Xanthomonas maltophilia: in vitro activity of beta-lactam/betalactamase inhibitor combinations. Diagn. Microbiol. Infect. Dis. 14:239-243.
143. Garcia-Rodriguez, J. A., J. E. Garcia Sanchez, J. L. Munoz Bellido, M. I. Garcia Garcia, and E. Garcia Sanchez. 1991. Kinetics of antimicrobial activity of aztreonam/clavulanic acid (2:1) against Xanthomonas maltophilia. J. Antimicrob. Chemother. 27:552-554.
144. Garcia-Rodriguez, J. A., J. E. Garcia Sanchez, J. L. Munoz Bellido, E. Garcia Sanchez, and M. I. Garcia Garcia. 1991. In vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia. J. Chemother. 3:143-146.
145. Gardner, P., W. B. Griffin, M. N. Swartz, and L. J. Kunz. 1970. Nonfermentative gram-negative bacilli of nosocomial interest. Am. J. Med. 48:735-749.
146. Garrison, M. W., D. E. Anderson, D. M. Campbell, K. C. Carroll, C. L. Malone, J. D. Anderson, R. J. Hollis, and M. J. Pfaller. 1996. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy in an in vitro pharmacodynamic chamber model. Antimicrob. Agents Chemother. 40:2859-2864.
147. Gerner-Smidt, P., B. Bruun, M. Arpi, and J. Schmidt. 1995. Diversity of nosocomial Xanthomonas maltophilia (Stenotrophomonas maltophilia) as determined by ribotyping. Eur. J. Clin. Microbiol. Infect. Dis. 14:137-140.
148. Gilardi, G. L. 1969. Pseudomonas maltophilia infections in man. Am. J. Clin. Pathol. 51:58-61.
149. Gilardi, G. L. 1971. Characterization of nonfermentative nonfastidious gram-negative bacteria encountered in medical bacteriology. J. Appl. Bacteriol. 34:623-644.
150. Gilardi, G. L, 1972. Infrequently encountered Pseudomonas species causing infection in humans. Ann. Intern. Med. 77:211-215.
151. Gilardi, G. L. 1973. Non-fermentative gram-negative bacteria encountered in clinical specimens. Antonie Leeuwenhoek 39:229-242.
152. Gilardi, G. L. 1976. Pseudomonas species in clinical microbiology. Mount Sinai J. Med. 43:710-726.
153. Girijaratnakumari, T., A. Raja, R. Ramani, B. Antony, and P. G. Shivananda. 1993. Meningitis due to Xanthomonas maltophilia. J. Postgrad. Med. 39:153-155.
154. Gladman, G., P. J. Connor, R. F. Williams, and T. J. David. 1992. Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Arch. Dis. Child. 67:192-195.
155. Gordon, G., M. Indeck, J. Bross, D. A. Kapoor, and S. Brotman. 1988. Injury from silage wagon accident complicated by mucormycosis. J. Trauma 28:866-867.
156. Gould, I. M., and K. Milne. 1997. In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin. J. Antimicrob. Chemother. 39:53-61.
157. Goze, A. 1973. Incidence des Pseudomonas sans pigment et des Moraxella en milieu hospitalier. Rev. Epidemiol. Med. Sec. Sante Publique 21:499-520.
158. Graham, D. Y., H. H. Yoshimura, and M. K. Estes. 1983. DNA hybridization studies of the association of Pseudomonas maltophilia with inflammatory bowel disease. J. Lab. Clin. Med. 101:940-954.
159. Grant, M. M., M. S. Niedermann, M. A. Poehlmann, and A. M. Fein. 1991. Characterisation of Pseudomonas aeruginosa adherence to cultured hamster tracheal epithelial cells. Am. J. Respir. Cell. Mol. Biol. 5:563-570.
160. Grehn, M. 1976. Über die Toxizität einiger Spezies sog. nicht fermentativer gramnegativer Bakterien. Zentralbl. Bakteriol. Parasitenkd. Infektranskr. Hyg. Abt. I Orig. Reihe A 235:84-89.
161. Grimard, D., and M. G. Bergeron. 1985. False resistance of Streptococcus faecalis and Pseudomonas maltophilia to norfloxacin by disc diffusion susceptibility testing. J. Antimicrob. Chemother. 16:132-133.
162. Grover, S., and W. D. Odell. 1992. Partial characterisation of the 30 kD Ig-binding protein from Pseudomonas maltophilia. Biochem. Biophys. Res. Commun. 182:1075-1081.
163. Grover, S., and W. D. Odell. 1993. Characterisation of the 48.5 kDa chorionic gonadotrophin-like protein from Xanthomonas maltophilia. Endocr. Res. 19:147-162.
164. Grover, S., S. R. Woodward, O. Caticha, D. T. Carrell, and W. D. Odell. 1993, Partial nucleotide sequence of the Xanthomonas maltophilia chorionic gonadotrophin-like receptor. Biochem. Biophys. Res. Commun. 190: 371-376.
165. Grover, S., S. R. Woodward, and W. D. Odell. 1993. A bacterial protein has homology with human chorionic gonadotrophin (hCG). Biochem. Biophys. Res. Commun. 193:841-847.
166. Grover, S., S. R. Woodward, and W. D. Odell. 1995. Complete sequence of the gene encoding a chorionic gonadotrophin-like protein from Xanthomonas maltophilia. Gene 156:75-78.
167. Guerzoni, M. E., R. Lanciotti, M. Sinigaglia, and F. Gardini. 1994. Analysis of the interaction between autochthonous bacteria and packaging material in PVC-bottled mineral water. Microb. Res. 149:115-122.
168. Gutierrez Rodera, F., M. del Mar Masia, J. Cortes, V. Ortiz de la Tabla, V. Mainar, and A. Vilar. 1996. Endocarditis caused by Stenotrophomonas maltophilia: case report and review. Clin. Infect. Dis. 23:1261-1265.
169. Hardy, D. J., B. B. Hulbert, and P. C. Migneault. 1992. Time to detection of positive BacT/Alert blood cultures and lack of need for routine subculture of 5-to 7-day negative cultures. J. Clin. Microbiol. 30:2743-2745.
170. Harlowe, H. D. 1972. Acute mastoiditis following Pseudomonas maltophilia infection. Laryngoscope 82:882-883.
171. Hawkey, P. M., D. Birkenhead, K. G. Kerr, K. E. Newton, and W. A. Hyde. 1993. Effect of divalent cations in bacteriological media in the susceptibility of Xanthomonas maltophilia to imipenem with special reference to zinc ions. J. Antimicrob. Chemother. 31:47-55.
172. Heath, T., and B. Currie. 1995. Nosocomial and community acquired Xanthomonas maltophilia infection in tropical Australia. J. Hosp. Infect. 30: 309-313.
173. Hebbar, P., O. Berge, T. Heulin, and S. P. Singh. 1991. Bacterial antagonists of sunflower (Helianthus annuus L.) fungal pathogens. Plant Soil 133:131-140.
174. Hellinger, W. C., J. J. Cawley, S. Alvarez, S. F. Hogan, W. S. Harmsen, D. M. Ilstrup, and F. R. Cockerill III. 1995. Clinical comparison of the Isolator and BacT/Alert aerobic blood culture systems. J. Clin. Microbiol. 33:1787-1790.
175. Henderson, E., Ledgerwood, K. Hope, G. Ross, W. Krulicki, and T. Louie. 1996. Screening and isolation for patients with multi-resistant organisms. Infect. Control Hosp. Epidemiol. 17:30.
176. Hernandez-Duquino, H., and F. A. Rosenberg. 1987. Antibiotic-resistant Pseudomonas in bottled drinking water. Can. J. Microbiol. 33:286-289.
177. Hirai, Y. 1991. Survival of bacteria under dry conditions: from a viewpoint of nosocomial infection. J. Hosp. Infect. 19:191-200.
178. Hohl, P., R. Frei, and P. Aubry. 1991. In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia: inconsistent correlation of agar dilution and of disk diffusion test results. Diagn. Microbiol. Infect. Dis. 14:447-450.
179. Holmes, B., M. Costas, T. Thaker, and M. Stevens. 1994. Evaluation of two BBL Crystal systems for identification of some clinically important gramnegative bacilli. J. Clin. Microbiol. 32:2221-2224.
180. Holmes, B., S. P. Lapage, and B. G. Easterling. 1979. Distribution in clinical material and identification of Pseudomonas maltophilia. J. Clin. Pathol. 32:66-72.
181. Hoppe, J. E., I. Holzwarth, and M. Stern. 1996. Comparison of four methods for pretreatment of cystic fibrosis sputum. Eur. J. Clin. Microbiol. Infect. Dis. 15:895-896.
182. Hosaka, M., T. Yasue, H. Fukuda, H. Tomizawa, H. Aoyama, and K. Hirai. 1992. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxyquinolone. Antimicrob. Agents Chemother. 36:2108-2117.
183. Hugh, R., and G. L. Gilardi. 1980. Pseudomonas, p. 288-317. In E. H. Lennette, A. Balows, W. Hausler, Jr., and J. P. Truant (ed.), Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington, D.C.
184. Hugh, R., and E. Leifson. 1963. A description of the type strain of Pseudomonas maltophilia. Int. Bull. Bacteriol. Nomencl. Taxon. 13:133-138.
185. Hugh, R., and E. Ryschenkow. 1960. An Alcaligenes-like Pseudomonas species. Bacteriol. Proc. 1960, p. 78.
186. Hugh, R., and E. Ryschenkow. 1961. Pseudomonas maltophilia, an Alcaligenes-like species. J. Gen. Microbiol. 26:123-132.
187. Hulisz, D. T., and T. M. File. 1992. Predisposing factors and antibiotic use in nosocomial infections caused by Xanthomonas maltophilia. Infect. Control Hosp. Epidemiol. 13:489-490.
188. Hupkova, M., J. Blahova, J. Kralikova, and V. Krcmery. 1995. Transferable resistance to beta-lactams in a nosocomial strain of Xanthomonas maltophilia. Antimicrob. Agents Chemother. 39:1011-1012.
189. Ianinni, P. B., M. J. Kunkel, E. Hilton, and G. M. Ianinni. 1985. Imipenem/ cilastatin: general experience in a community hospital. Am. J. Med. 78(Suppl. 6A): 122-126.
190. Ibbotson, J. P., P. E. Pease, and R. N. Allen. 1987. Serological studies in Crohn's disease. Eur. J. Clin. Microbiol. 6:286-290.
191. Iizuka, H., and K. Komagata. 1964. Microbiological studies on petroleum and natural gas. I. Determination of hydrocarbon-utilizing bacteria. J. Gen. Appl. Microbiol. 10:207-221.
192. Iizuka, H., and K. Komagata. 1963. Taxonomy of the genus Pseudomonas with special reference to their modes of metabolism of carbon compounds. J. Gen. Appl. Microbiol. 9:83-95.
193. Ikemoto, S., K. Suzuki, T. Kaneko, and K. Komagata. 1980. Characterization of strains of Pseudomonas maltophilia which do not require methionine. Int. J. Syst. Bacteriol. 30:437-447.
194. Irifune, K., T. Ishida, K. Shimoguchi, J. Ohtake, T. Tanaka, N. Morikawa, M. Kaku, H. Koga, S. Kohno, and K. Hara. 1994. Pneumonia caused by Stenotrophomonas maltophilia with a mucoid phenotype. J. Clin. Microbiol. 32:2856-2857.
195. Jakobi, M., G. Winkelmann, D. Kaiser, C. Kempler, G. Jung, G. Berg, and H. Bahl. 1996. Maltophilin: a new antifungal compound produced by Stenotrophomonas maltophilia R3089. J. Antibiot. 49:1101-1104.
196. Janda, J. M., and E. J. Bottone. 1985. Pathogenic properties and enzyme profiles of Pseudomonas and Acinetobacter, p. 233-254. In G. L. Gilardi (ed.), Non-fermentative gram-negative rods: laboratory identification and clinical aspects. Marcel Dekker, Inc., New York, N.Y.
197. Jang, T.-N., F.-D. Wang, L.-H. Wang, C.-Y. Lin, and I.-M. Liu. 1992. Xanthomonas maltophilia bacteremia: an analysis of 32 cases. J. Formosan Med. Assoc. 91:1170-1176.
198. Jones, R. N. 1995. Isepamicin (SCH 21420, 1-N-HAPA gentamicin B); microbiological characteristics including antimicrobial potency of spectrum of activity. J. Chemother. 7(Suppl. 2):7-16.
199. Jones, R. N., and M. E. Erwin. 1992. In vitro activity of CP-74667 compared with four other fluoroquinolones. Diagn. Microbiol. Infect. Dis. 15:531-536.
200. Jucker, B. A., H. Harms, and A. J. B. Zehnder. 1996. Adhesion of the positively charged bacterium Stenotrophomonas (Xanthomonas) maltophilia 70401 to glass and Teflon. J. Bacteriol. 178:5472-5479.
201. Juffs, H. S. 1973. Identification of Pseudomonas species isolated from milk produced in South Eastern Queensland. J. Appl. Bacteriol. 36:585-598.
202. Juhnke, M. E., and E. Des Jardin. 1989. Selective medium for isolation of Xanthomonas maltophilia from soil and rhizosphere environments. Appl. Environ. Microbiol. 55:747-750.
203. Juhnke, M. E., D. E. Mathre, and D. C. Sands. 1987. Identification and characterization of rhizosphere competent bacteria of wheat. Appl. Environ. Microbiol. 53:2793-2794.
204. Kaiser, G. M., P. C. Tso, R. Morris, and D. McCurdy. 1997. Xanthomonas maltophilia endophthalmitis after cataract extraction. Am. J. Ophthalmol. 123:410-411.
205. Kampfer, P., and W. Dott. 1989. Evaluation of the Titertek-NF system for identification of gram-negative bacteria. J. Clin. Microbiol. 27:1201-1205.
206. Karalus, N. C., R. T. Cursons, R. A. Leng, C. B. Mahood, R. P. G. Rothwell, B. Hancock, S. Cepulis, M. Wawatai, and L. Coleman. 1991. Community-acquired pneumonia: aetiology and prognostic index evaluation. Thorax 46:413-416.
207. Karpati, F., A. S. Malmborg, H. Alfredsson, L. Hjelte, and B. Strandvik. 1994. Bacterial colonisation with Xanthomonas maltophilia - a retrospective study in a cystic fibrosis patient population. Infection 22:258-263.
208. Kato, N., and T. Morioka. 1991. Purpura fulminans secondary to Xanthomonas maltophilia sepsis in an adult with aplastic anaemia. J. Dermatol. 18:225-229.
209. Kawai, F. 1993. Bacterial degradation of acrylic oligomers and polymers. Appl. Microbiol. Biotechnol. 39:382-385.
210. Kealey, G. P., and A. E. Cram. 1986. Pseudomonas maltophilia: an unusual burn wound pathogen. J. Burn Care Rehab. 7:409-410.
211. Kelly, L. D., and L.-J. Xu. 1996. The effect of concurrent Pseudomonas or Xanthomonas exposure on adherence of Acanthamoeba castellani to soft contact lenses. Graefe's Arch. Clin. Exp. Ophthalmol. 234:311-314.
212. Kelly, M. D., J. E. Mortensen, B. A. Konkle, and T. L. Stull. 1995. A plasmid mediating production of a β-lactamase by Stenotrophomonas maltophilia. Curr. Ther. Res. 56:152-162.
213. Kerr, J. R. 1996. Inhibition of growth of fungi pathogenic to man by Stenotrophomonas maltophilia. J. Med. Microbiol. 45:380-382.
214. Kerr, K. G., J. Anson, P. M. Hawkey. 1994. Adherence of clinical and environmental strains of Xanthomonas maltophilia to plastic material, abstr. B-339. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
215. Kerr, K. G., C. M. Corps, and P. M. Hawkey. 1991. Infections due to Xanthomonas maltophilia in patients with hematologic malignancy. Rev. Infect. Dis. 13:762.
216. Kerr, K. G., M. Denton, N. J. Todd, C. M. Corps, P. Kumari, and P. M. Hawkey. 1996. A novel selective culture medium for the isolation of Stenotrophomonas maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 15:607-610.
217. Kerr, K. G., and P. M. Hawkey. 1995. Serum resistance of clinical and environmental strains of Stenotrophomonas maltophilia, abstr. 29. In Abstracts of the 2nd International Symposium on Febrile Neutropenia 1995.
218. Kerr, K. G., P. M. Hawkey, J. A. Child, D. R. Norfolk, and A. W. Anderson. 1990. Pseudomonas maltophilia infections in neutropenic patients and the use of imipenem. Postgrad. Med. J. 66:1090.
219. Kerr, K. G., and F. H. Wilkinson. Bottled water as a source of Stenotrophomonas maltophilia and Pseudomonas spp for neutropenic patients. Eur. J. Cancer Care, in press.
220. Khardori, N., L. Elting, E. Wong, B. Schable, and G. P. Bodey. 1991. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev. Infect. Dis. 12:997-1003.
221. Khardori, N., A. Reuben, B. Rosenbaum, K. Rolston, and G. P. Bodey. 1990. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob. Agents Chemother. 34:1609-1610.
222. Kiehn, T. E., and D. Armstrong. 1990. Changes in the spectrum of organisms causing bacteraemia and fungaemia in immunocompromised patients due to venous access devices. Eur. J. Clin. Microbiol. 9:869-872.
223. King, A., L. Bethune, and I. Phillips. 1991. The in vitro activity of levafloxacin compared with other antimicrobial agents. J. Antimicrob. Chemother. 27:769-779.
224. King, A., L. Bethune, and I. Phillips. 1991. The in vitro activity of tosufloxacin, a new fluorinated quinolone compared with that of ciprofloxacin and temofloxacin. J. Antimicroh. Chemother. 28:719-725.
225. King, B. A., K. P. Shannon, and I. Phillips. 1978. Aminoglycoside-6′-N-acetyltransferase production by an isolate of Pseudomonas maltophilia. J. Antimicrob. Chemother. 4:467-468.
226. Kirkley, B. A., K. A. Easley, B. A. Basille, and J. A. Washington. 1993. Controlled clinical comparison of two lysis-based blood culture systems, Isolator and Septi-Chek Release, for detection of bloodstream infections. J. Clin. Microbiol. 31:2114-2117.
227. Kirkley, B. A., K. A. Easley, and J. A. Washington. 1994. Controlled clinical evaluation of Isolator and ESP aerobic blood culture systems for detection of bloodstream infections. J. Clin. Microbiol. 32:1547-1549.
228. Kiska, D. L., A. Kerr, M. C. Jones, J. A. Caracciolo, B. Eskridge, M. Jordan, S. Miller, D. Hughes, N. King, and P. H. Gilligan. 1996. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:886-891.
229. Kitch, T. T., M. R. Jacobs, and P. C. Applebaum. 1992. Evaluation of the 4-hour RapID NF Plus method for identification of 345 gram-negative nonfermentative rods. J. Clin. Microbiol. 30:1267-1270.
230. Klick, J. M., and G. C. Du Moulin. 1978. An oxygen analyzer as a source of Pseudomonas. Anesthesiology 49:293-294.
231. Klinger, J. D., and M. J. Thomassen. 1985. Occurrence and antimicrobial susceptibility of gram-negative non-fermentative bacilli in cystic fibrosis patients. Diagn. Microbiol. Infect. Dis. 3:149-158.
232. Kobayashi, D. Y., M. Guglielmoni, and B. B. Clarke. 1995. Isolation of the chitinolytic bacteria Xanthomonas maltophilia and Serratia marcescens as biological control agents for summer patch disease of turf grass. Soil Biol. Biochem. 27:1479-1487.
233. Kollef, M. H., P. Silver, D. M. Murphy, and E. Trouillon. 1995. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 108:1655-1662.
234. Komagata, K. 1961. Differentiation of genus Pseudomonas and related aerobic bacteria. J. Gen. Appl. Microbiol. 7:282-299.
235. Komagata, K., Y. Yabuuchi, V. Tamagawa, and A. Ohyama. 1974. Pseudomonas melanogena Iizuka and Komagata 1963, a later subjective synonym of Pseudomonas maltophilia Hugh and Ryschenkow 1960. Int. J. Syst. Bacteriol. 24:242-247.
236. Korn, C., R. Burke, C. O'Donnell, and E. Smail. 1996. An outbreak of Stenotrophomonas (Xanthomonas) maltophilia associated with reusable in-line ventilator temperature probes. Infect. Control Hosp. Epidemiol. 17(Suppl.):P48.
237. Krachmer, J. H., and J. J. Purcell. 1978. Bacterial corneal ulcers in cosmetic soft contact lens wearers. Arch. Ophthalmol. 96:57-61.
238. Krcmery, V., Jr., P. Pichna, E. Oravcova, J. Lacka, E. Kukuckova. M. Studena, S. Grausova, K. Stopkova, and I. Krupova. 1996. Stenotrophomonas maltophilia bacteraemia in cancer patients: report on 31 cases. J. Hosp. Infect. 34:75-77.
239. Kwok, O. C. H., P. C. Fahy, H. A. J. Hoitink, and G. A. Kuter. 1987. Interactions between bacteria and Trichoderma hamatum in suppression of Rhizoctonia damping-off in bark compost media. Phytopathology 77:1206-1212.
240. Labows, J. N., K. J. McGinley, G. F. Webster, and J. J. Leyden. 1980. Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry. J. Clin. Microbiol. 12:521-526.
241. Laing, F. P. Y., K. Ramotar, R. R. Read, N. Alfieri, A. Kureishi, E. A. Henderson, and T. J. Louie. 1995. Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment. J. Clin. Microbiol. 33:513-518.
242. Lambert, B., F. Beyns, L. Van Rooyen, F. Gossele, Y. Papon, and J. Swings. 1987. Rhizobacteria of maize and their antifungal activities. Appl. Environ. Microbiol. 53:1866-1871.
243. Lambert, B., P. Meire, H. Joos, P. Lens, and J. Swings. 1990. Fast-growing aerobic heterotrophic bacteria from the rhizosphere of young sugar beet plants. Appl. Environ. Microbiol. 56:3375-3381.
244. Lee, N. A., and D. P. Clark. 1993. A natural isolate of Pseudomonas maltophilia which degrades aromatic sultonic acids. FEMS Microbiol. Lett. 107:151-155.
245. Lee, N.-R., M.-O. Hwang, G.-H. Jung, Y.-S. Kim, and K.-H. Min. 1996. Physical structure and expression of alkBA encoding alkane hydroxylase and rubredoxin reductase from Pseudomonas maltophilia. Biochem. Biophys. Res. Commun. 218:17-21.
246. Lesco-Bornet, M., J. Pierre, D. Sarkis-Karam, S. Lubera, and E. Bergogne-Berezin. 1992. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob. Agents Chemother. 36:669-671.
247. Liaw, Y. S., P. C. Yang, Z. G. Wu, C. J. Yu, D. B. Chang, L. N. Lee, S. H. Kuo, and K. T. Luh. 1994. The bacteriology of obstructive pneumonitis: a prospective study using ultrasound-guided transthoracic needle aspiration. Am. J. Respir. Crit. Care Med. 149:1648-1653.
248. Litopoulou-Tzanetaki, E., and A. Vafopoulou-Mastrojiannaki. 1995. Hydrolase activities of whole cells and crude cell-free extract of gram-negative isolates from refrigerated raw ewe milk. Milchwissenschaft 50:610-614.
249. Liu, P. Y.-F., Y.-J. Lau, B.-S. Hu, J.-M. Shyr, Z.-Y. Shi, W.-S. Tsai, Y.-H. Lin, and C.-Y. Tseng. 1995. Comparison of susceptibility to extended-spectrum β-lactam antibiotics and ciprofloxacin among gram-negative bacilli isolated from intensive care units. Diagn. Microbiol. Infect. Dis. 22: 285-291.
250. Lookingbill, D. P., S. H. Miller, and R. C. Knowles. 1978. Bacteriology of chronic leg ulcers. Arch. Dermatol. 114:1765-1768.
251. Louie, A., A. L. Baltch, W. J. Ritz, and R. P. Smith. 1991. Comparative in vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas species to sparfloxacin, CI-978, AT4140, PD131501, and reference antimicrobial agents. J. Antimicrob. Chemother. 27:793-799.
252. Lysenko, O., and J. Weiser. 1974. Bacteria associated with the nematode Neoaplectana carpocapsae and the pathogenicity of this complex for Galleria mellonella larvae. J. Invertebr. Pathol. 24:332-336.
253. MacDiarmid, J. A., and D. H. Burrell. 1993. Degradation of the wool fibre by bacteria isolated from fleece rot. Wool Technol. Sheep Breed. 40:123-126.
254. Maes, M. 1993. Fast classification of plant-associated bacteria in the Xanthomonas genus. FEMS Microbiol. Lett. 113:161-166.
255. Malecka-Griggs, B., and D. J. Reinhardt. 1983. Direct dilution sampling, quantitation, and microbial assessment of open-system ventilation circuits in intensive care units. J. Clin. Microbiol. 17:870-877.
256. Manian, F. A., L. Meyer, J. Jenne, A. Owen, and T. Taff. 1996. Loss of antimicrobial susceptibility in aerobic gram-negative bacilli repeatedly isolated from patients in intensive care units. Infect. Control Hosp. Epidemiol. 17:222-226.
257. Maningo, E., and C. Watanakunakorn. 1995. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J. Infect. 31:89-92.
258. Margesin, R., and F. Schinner. 1991. Characterization of a metalloprotease from psychrophilic Xanthomonas maltophilia. FEMS Microbiol. Lett. 79: 257-261.
259. Markowitz, S. M., D. S. Williams, C. B. Hanna, J. L. Parker, M. A. Pierce, and J. C. Steele, Jr. 1995. A multi-center comparative study of the in vitro activity of fleroxacin and other antibacterial agents. Chemotherapy 41:477-486.
260. Marraro, R. V., and J. L. Mitchell. 1974. Exogenous methionine requirements of Pseudomonas maltophilia. J. Am. Med. Technol. 36:239-240.
261. Marrie, T. J., H. Durrant, and L. Yates. 1989. Community-acquired pneumonia requiring hospitalisation: five year prospective study. Rev. Infect. Dis. 11:586-599.
262. Marshall, W. F., M. R. Keating, J. P. Anhalt, and J. M. Steckelberg. 1989. Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin. Proc. 64:1097-1104.
263. Martin, R., F. Siavoshi, and D. L. McDougal. 1986. Comparison of RapID NFT system and conventional methods for identification of nonsaccharolytic gram-negative bacteria. J. Clin. Microbiol. 24:1089-1092.
264. Mazzola, M., P. W. Stahlman, and J. E. Leach. 1995. Application method affects the distribution and efficacy of rhizobacteria suppressive of downy brome (Bromus tectorum). Soil Biol. Biochem. 27:1271-1278.
265. McDonald, G. R., and R. Pernenkil. 1993. Community-acquired Xanthomonas maltophilia pyelonephritis. South. Med. J. 86:967-968.
266. McKee, K. T., M. A. Melly, H. L. Greene, and W. Schaffner. 1979. Gram-negative bacillary sepsis associated with use of lipid emulsion in parenteral nutrition. Am. J. Dis. Child. 133:649-650.
267. Meier, S., G. Zellweger, P. Elsner, D. Wurtnrich, and M. Krause. 1994. Purpura fulminans bei Morbus Still und Bakteriamie mit Xanthomonas maltophilia und koagulase negativen Staphylokokken. Schweiz. Med. Wochenschr. 124:900-905.
268. Metchock, B., and C. Thornsberry. 1989. Susceptibility of Xanthomonas (Pseudomonas) maltophilia to antimicrobial agents: methodological problems. Antimicrob. Newsl. 6:35-40.
269. Mett, H., S. Rosta, B. Schacher, and R. Frei. 1988. Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. Rev. Infect. Dis. 10:765-769.
270. Midelfart, J., A. Midelfart, and L. Bevanger. 1996. Microbial contamination of contact lens cases among medical students. CLAO J. 22:21-24.
271. Miller, J. M., and D. L. Rhoden. 1991. Preliminary evaluation of Biolog, a carbon source utilization method for bacterial identification. J. Clin. Microbiol. 29:1143-1147.
272. Minah, G. E., J. L. Rednor, D. E. Peterson, C. D. Overholser, L. G. Depaola, and J. B. Suzuki. 1986. Oral succession of gram-negative bacilli in myelosuppressed cancer patients. J. Clin. Microbiol. 24:210-213.
273. Mirgain, I., G .A. Green, and H. Monteil. 1993. Degradation of atrazine in laboratory microcosms: isolation and identification of the biodegrading bacteria. Environ. Toxicol. Chem. 12:1627-1634.
274. Moffet, H. L., D. Allan, and T. Williams. 1967. Survival and dissemination of bacteria in nebulisers and incubators. Am. J. Dis. Child. 114:13-20.
275. Moffet, H. L., and T. Williams. 1967. Bacteria recovered from distilled water and inhalation equipment. Am. J. Dis. Child. 114:7-11.
276. Moody, M. R., and V. M. Young. 1975. In vitro susceptibility of Pseudomonas cepacia and Pseudomonas maltophilia to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrob. Agents Chemother. 7:836-839.
277. Moody, M. R., V. M. Young, and D. M. Kenton. 1972. In vitro antibiotic susceptibility of Pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob. Agents Chemother. 2:344-349.
278. Morello, J. A., C. Leitch, S. Nitz, J. W. Dyke, M. Andruszewski, G. Maier, W. Landau, and M. A. Beard. 1994. Detection of bacteremia by Ditco ESP blood culture system. J. Clin. Microbiol. 32:811-818.
279. Morrison, A. J., Jr., K. K. Hoffmann, and R. P. Wenzel. 1986. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J. Clin. Microbiol. 24:52-55.
280. Mortensen, J. E., M. C. Fisher, and J. J. LiPuma. 1995. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect. Control Hosp. Epidemiol. 16:30-32.
281. Moss, C. W., S. B. Samuels, J. Liddle, and R. M. McKinney. 1973. Occurrence of branched chain hydroxy fatty acids in Pseudomonas maltophilia. J. Bacteriol. 114:1018-1025.
282. Moss, C. W., S. B. Samuels, and R. E. Weaver. 1972. Cellular fatty acid composition of selected Pseudomonas species. Appl. Microbiol. 24:596-598.
283. Moss, R. B. 1995. Cystic fibrosis: pathogenesis, pulmonary infection, and treatment. Clin. Infect. Dis. 21:839-851.
284. Muder, R. R., A. P. Harris, S. Muller, M. Edmond, J. W. Chow, K. Papadakis, M. W. Wagener, G .P. Bodey, and J. M. Steckelberg. 1996. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective multi-center study of 91 episodes. Clin. Infect. Dis. 22:508-512.
285. Muder, R. R., V. L. Yu, J. S. Dummer, C. Vinson, and R. M. Lumish. 1987. Infections caused by Pseudomonas maltophilia: expanding clinical spectrum. Arch. Intern. Med. 147:1672-1674.
286. Munoz, J. L., M. I. Garcia, S. Munoz, S. Leal, M. Fajardo, and J. A. Garcia-Rodriguez. 1996. Activity of trimethoprim/sulfamethoxazole plus polymyxin B against multiresistant Stenotrophomonas maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 15:879-882.
287. Nagai, T. 1984. Association of Pseudomonas maltophilia with malignant lesions. J. Clin. Microbiol. 20:1003-1005.
288. Nakatsu, C. H., R. R. Fulthorpe, B. A. Holland, M. C. Peel, and R. C. Wyndham. 1995. The phylogenetic distribution of a transposable dioxygenase from the Niagara River watershed. Mol. Ecol. 4:593-603.
289. Narasimhan, S. L., D. L. Gopaul, and L. A. Hatch. 1977. Pseudomonas maltophilia bacteremia associated with a prolapsed mitral valve. Am. J. Clin. Pathol. 68:304-306.
290. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
291. Nawaz, M. S., W. Franklin, and C. E. Cerniglia. 1993. Degradation of acrylamide by immobilised cells of a Pseudomonas sp. and Xanthomonas maltophilia. Can. J. Microbiol. 39:207-212.
292. Neal, D. J., and S. G. Wilkinson. 1982. Lipopolysaccharides from Pseudomonas maltophilia: structural studies of the side chain, core, and lipid A regions of the Iipopolysaccharide from strain NCTC 10257. Eur. J. Biochem. 128:143-149.
293. Nesme, X., M. Vaneechoutte, S. Orso, B. Hoste, and J. Swings. 1995. Diversity and genetic relatedness within genera Xanthomonas and Stenotrophomonas using restriction endonuclease site differences of PCR-amplified 16S rRNA gene. Syst. Appl. Microbiol. 18:127-135.
294. Neu, H., G. Saha, and N. Chin. 1991. Resistance of Xanthomonas maltophilia to antibiotics and the effect of β-lactamase inhibitors. Diagn. Microbiol. Infect. Dis. 12:283-285.
295. Nguyen, M. H., and R. R. Muder. 1994. Meningitis due to Xanthomonas maltophilia: case report and review. Clin. Infect. Dis. 19:325-326.
296. Noble, R. C., and M. C. Parekh. 1987. In vitro comparison of ceftazidime, aztreonam, cefpirome, gentamicin, imipenem, cnoxacin, and ticarcillin plus clavulanic acid against 108 strains of Pseudomonas maltophilia. Curr. Microbiol. 15:177-179.
297. Nolte, F. S., J. M. Williams, R. C. Jerris, J. A. Morello, C. D. Leiten, S. Matushek, L. D. Schwabe, F. Dorigan, and F. E. Kocka. 1993. Multicenter clinical evaluation of a continuous monitoring blood culture system using fluorescent-sensor technology (BACTEC 9240). J. Clin. Microbiol. 31:552-557.
298. Nord, C.-E., L. Sjoberg, T. Wadstrom, and B. Wretlind. 1975. Characterization of three Aeromonas and nine Pseudomonas species by extracellular enzymes and haemolysins. Med. Microbiol. Immunol. 161:79-87.
299. Nord, C.-E., T. Wadstrom, and B. Wretlind. 1974. Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob. Agents Chemother. 6:521-523.
300. Nord, C.-E., T. Wadstrom, and B. Wretlind. 1975. Antibiotic sensitivity of two Aeromonas and nine Pseudomonas species. Med. Microbiol. Immunol. 161:89-97.
301. Noskin, G. A., and S. M. Grohmann. 1992. Xanthomonas maltophilia bacteremia: an analysis of factors influencing outcome. Infect. Dis. Clin. Pract. 1:230-236.
302. O'Brien, M., and G. H. G. Davis. 1981. Fibrinolysis as an aid in the identification of Pseudomonas species. Microbios Lett. 16:41-43.
303. O'Brien, M., and G. H. Davis. 1982. Enzymatic profile of Pseudomonas maltophilia. J. Clin. Microbiol. 16:417-421.
304. O'Hara, C. M., F. C. Tenover, and J. M. Miller. 1993. Parallel comparison of accuracy of API 20E, Vitek GNI, MicroScan Walk/Away Rapid ID, and Becton Dickinson Cobas Micro ID-E/NF for identification of members of the family Enterobacteriaceae and common gram-negative, non-glucose-fermenting bacilli. J. Clin. Microbiol. 31:3165-3169.
305. Oie, S., and A. Kamiya. 1992. Microbial contamination of brushes used for pre-operative shaving. J. Hosp. Infect. 21:103-110.
306. Olsen, P. E., W. A. Rice, L. M. Bordeleau, A. H. Demidoff, and M. M. Collins. 1996. Levels and identities of nonrhizobial microorganisms found in commercial legume inoculant made with non-sterile peat carrier. Can. J. Microbiol. 42:72-75.
307. Omri, A., and M. Ravaoarinoro. 1996. Preparation, properties, and the effects of amikacin, netilmicin, and tobramycin in free and liposomal formulations on gram-negative and gram-positive bacteria. Int. J. Antimicrob. Agents 7:9-14.
308. Orr, K., F. K. Gould, P. R. Sisson, N. F. Lightfoot, R. Freeman, and D. Burdess. 1991. Rapid inter-strain comparison by pyrolysis mass spectrometry in nosocomial infection with Xanthomonas maltophilia. J. Hosp. Infect. 17:187-195.
309. Orrison, L. H., W. F. Bibb, W. B. Cherry, and L. Thacker. 1983. Determination of antigenic relationships among legionellae and non-legionellae by direct fluorescent-antibody and immunodiffusion tests. J. Clin. Microbiol. 17:332-337.
310. Osterhout, G. J., V. H. Shull, and J. D. Dick. 1991. Identification of clinical isolates of gram-negative nonfermentative bacteria by an automated cellular fatty acid identification system. J. Clin. Microbiol. 29:1822-1830.
311. Oyiazu, H., and K. Komagata. 1983. Grouping of Pseudomonas species on the basis of cellular fatty acid compositions and the quinone system with special reference to the existence of 3-hydroxy fatty acids. J. Gen. Appl. Microbiol. 29:17-40.
312. Palleroni, N. J. 1984. Genus I. Pseudomonas Migula 1894, p. 141-199. In N. R. Krieg and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. The Williams & Wilkins Co., Baltimore, Md.
313. Palleroni, N. J., and J. F. Bradbury. 1993. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int. J. Syst. Bacteriol. 43:606-609.
314. Palleroni, N. J., R. Kunisawa, R. Contopoulou, and M. Doudoroff. 1973. Nucleic acid homologies in the genus Pseudomonas. Int. J. Syst. Bacteriol. 23:333-339.
315. Pankuch, G. A., M. R. Jacobs, and P. C. Applebaum. 1994. Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD131628, PD138312, PD140248, ciprofloxacin, and ofloxacin. Antimicrob. Agents Chemother. 38:369-370.
316. Pankuch, G. A., M. R. Jacobs, S. F. Rittenhouse, and P. C. Applebaum. 1994. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight β-lactams (including β-lactam-β-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrob. Agents Chemother. 38: 2317-2322.
317. Papadakis, K. A., S. E. Vartivarian, M. E. Vassilaki, and E. J. Anaissie. 1995. Stenotrophomonas maltophilia: an unusual cause of biliary sepsis. Clin. Infect. Dis. 21:1032-1034.
318. Papadakis, K. A., S. E. Vartivarian, M. E. Vassilaki, and E. J. Anaissie. 1996. Septic pre-patellar bursitis caused by Stenotrophomonas (Xanthomonas) maltophilia. Clin. Infect. Dis. 22:388-389.
319. Papapetropolou, M., J. Iliopolou, G. Rodopolou, J. Detorakis, and O. Paniara. 1994. Occurrence and antibiotic resistance of Pseudomonas species isolated from drinking water in southern Greece. J. Chemother. 6:111-116.
320. Papapetropolou, M., G. Rodopolou, E. Giannoulaki, and P. Stergiopoulos. 1994. Effect of temperature on antimicrobial susceptibilities of Pseudomonas species isolated from drinking water. J. Chemother. 6:404-407.
321. Parent, K., and P. D. Mitchell. 1976. Bacterial variants: etiological agent in Crohn's disease. Gastroenterology 71:365-368.
322. Parent, K., and P. Mitchell. 1978. Cell wall-defective variants of Pseudomonas-like (group Va) bacteria in Crohn's disease. Gastroenterology 75: 368-372.
323. Parr, M. D., K. E. Bertch, and R. P. Rapp. 1985. Amino-acid stability and microbial growth in total parenteral nutrient solutions. Am. J. Hosp. Pharm. 42:2688-2691.
324. Pasadakis, P., E. Thodis, A. Eftimimiadou, S. Panagoutsos, D. Papazoglou, M. Kaliengidou, S. Kartali, and V. Vargemezis. 1993. Treatment and prevention of relapses of CAPD Pseudomonas peritonitis. Adv. Periton. Dial. 9:206-210.
325. Pasargiklian, I., G. Lusco, G. Paizis, and E. Mascheroni. 1995. Ticarcillin/ clavulanic acid: determination of minimal inhibitory concentrations against bacterial strains isolated from intensive care units. Comparison with other strains. J. Chemother. 8:113-121.
326. Paton, R., R. S. Miles, and S. G. B. Amyes. 1994. Biochemical properties of inducible β-lactamases produced from Xanthomonas maltophilia. Antimicrob. Agents Chemother. 38:2143-2149.
327. Patrick, S., J. M. Hindmarch, R. V. Hague, and D. M. Harris. 1975. Meningitis caused by Pseudomonas maltophilia. J. Clin. Pathol. 28:741-743.
328. Payne, D. J., J. H. Bateson, B. C. Gasson, D. Proctor, T. Khushi. T. H. Farmer, D. A. Toison, D. Bell, P. W. Skett, A. C. Marshall, R. Reid, L. Ghosez, Y. Combret, and J. Marchand-Brynaert. 1997. Inhibition of metallo-β-lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrob. Agents Chemother. 41:135-140.
329. Payne, D. J., R. Cramp, J. H. Bateson, J. Neale, and D. Knowles. 1994. Rapid identification of metallo- and serine beta-lactamases. Antimicrob. Agents Chemother. 38:991-996.
330. Pedersen, M. M., E. Marso, and J. Pickett. 1970. Non-fermentative bacilli associated with man. III. Pathogenicity and antibiotic susceptibility. Am. J. Clin. Pathol. 54:178-192.
331. Penland, R. L., and K. R. Wilhemus. 1996. Stenotrophomonas maltophilia ocular infections. Arch. Ophthalmol. 114:433-436.
332. Pfaller, M. A., D. Sahm, C. O'Hara, C. Ciaglia, M. Yu, N. Yamane, G. Scharnweber, and D. Rhoden. 1991. Comparison of the autoSCAN-W/A rapid bacterial identification system and the Vitek AutoMicrobic system for identification of gram-negative bacilli. J. Clin. Microbiol. 29:1422-1428.
333. Phale, P. S., M. C. Mahajan, and C. S. Vaidyanathan. 1995. A pathway for biodegradation of 1-naphthoic acid by Pseudomonas maltophilia CSU89. Arch. Microbiol. 163:42-47.
334. Pham, B. N., S. Aractingi, H. Dombret, G. Arlet, M. Hunault, and L. Degos. 1992. Xanthomonas (formerly Pseudomonas) maltophilia-induced cellulitis in a neutropenic patient. Arch. Dermatol. 128:702-704.
335. Phillips, I., B. A. King, and K. P. Shannon. 1978. The mechanisms of resistance to aminoglycosides in the genus Pseudomonas. J. Antimicrob. Chemother. 4:121-129.
336. Piddock, L. J., and H. L. Turner. 1992. Activity of meropenem against imipenem-resistant bacteria and selection in vitro of carbapenem-resistant Enterobacteriaceae. Eur. J. Clin. Microbiol. Infect. Dis. 11:1186-1191.
337. Pitt, T. L. 1991. Burnt offerings or typing system. J. Hosp. Infect. 17:157-158.
338. Pohlman, J. K., B. A. Kirkley, K. A. Easley, B. A. Basilic, and J. A. Washington. 1995. Controlled clinical evaluation of BACTEC Plus Aerobic/F and BacT/Alert Aerobic FAN bottles for detection of bloodstream infections. J. Clin. Microbiol. 33:2856-2858.
339. Pohlman, J. K., B. A. Kirkley, K. A. Easley, and J. A. Washington. 1995. Controlled clinical comparison of Isolator and BACTEC 9240 Aerobic/F Resin bottle for detection of bloodstream infections. J. Clin. Microbiol. 33:2525-2529.
340. Poulos, C. D., S. O. Matsumura, B. M. Willey, D. E. Low, and A. McGeer. 1995. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia. Antimicrob. Agents Chemother. 39: 2220-2223.
341. Pradahananga, S. L., P. J. E. Rowling, I. N. Simpson, and D. J. Payne. 1996. Sensitivity of L2-type beta-lactamases from Stenotrophomonas maltophilia to serine active site beta-lactamase inhibitors. J. Antimicrob. Chemother. 37:394-396.
342. Public Health Laboratory Service. 1993. Ice as a source of infection acquired in hospital. CDR Weekly 3:53.
343. Puckey, D. J., J. R. Norris, and C. S. Gutteridge. 1980. Discrimination of micro-organisms using direct probe mass spectrometry. J. Gen. Microbiol. 118:535-538.
344. Qadri, S. M. H., H. Abo-Askar, and Y. Veno. 1992. Antibacterial activity of the new quinolone CI-960 (PD127391) against clinical isolates at a major tertiary care center in Saudi Arabia. Chemotherapy (Basel) 38:92-98.
345. Qadri, S. M. H., Y. Veno, J. V. Burns, E. Almodovar, and N. Rabea. 1992. In vitro activity of sparfloxacin (CI-978), a new broad spectrum fluoroquinolone. Chemotherapy (Basel) 38:99-106.
346. Qadri, S. M. H., Y. Veno, H. Saldin, J. M. Burdette, and G. C. Lee. 1992. Comparative antibacterial activity of the new fluoroquinolone PD 131628. Drug Invest. 4:409-415.
347. Rahmati-Bahram, A., J. T. Magee, and S. K. Jackson. 1995. Growth temperature-dependent variation of cell-envelope lipids and antibiotic susceptibility in Stenotrophomonas (Xanthomonas) maltophilia. J. Antimicrob. Chemother. 36:317-326.
348. Rahmati-Bahram, A., J. T. Magee, and S. K. Jackson. 1996. Temperature-dependent aminoglycoside resistance in Stenotrophomonas (Xanthomonas) maltophilia: alterations in protein and lipopolysaccharide with growth temperature. J. Antimicrob. Chemother. 37:665-676.
349. Rahmati-Bahram, A., J. T. Magee, and S. K. Jackson. 1997. Effect of temperature on aminoglycoside binding sites in Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 39:19-24.
350. Ravizzola, G., R. Pizzi, F. Pirali, and A. Turano. 1994. In vitro antibacterial activity of the new quinolone Bay y3118 against clinical isolates. J. Chemother. 6:392-398.
351. Rello, J., E. Quintana, V. Ausina, J. Castella, M. Luquin, A. Net, and G. Prats. 1991. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 100:439-444.
352. Rhoden, U. L., B. Schable, and P. B. Smith. 1987. Evaluation of PASCO MIC-ID system for identifying gram-negative bacilli. J. Clin. Microbiol. 25:2363-2366.
353. Richert, N. D., and R. J. Ryan. 1977. Specific gonadotrophin binding to Pseudomonas maltophilia. Proc. Natl. Acad. Sci. USA 74:878-882.
354. Ringertz, S., A. Bjorklind, and G. Kronvall. 1989. Species-specific interpretive breakpoints for ciprofloxacin disk diffusion susceptibility testing. Scand. J. Infect. Dis. Suppl. 60:46-53.
355. Rivera, J. O., and D. M. Lutomski. 1984. Co-trimoxazole use for resistant Pseudomonas maltophilia. Clin. Pharm. 3:308-311.
356. Robinson, A., Y. S. McCarter, and J. Tetreault. 1995. Comparison of Crystal Enteric/Nonfermenter system, API 20E system, and Vitek AutoMicrobic system for identification of gram-negative bacilli. J. Clin. Microbiol. 33:364-370.
357. Rohner, P., B. Pepey, and R. Auckenthaler. 1995. Comparison of BacT/ Alert with Signal blood culture system. J. Clin. Microbiol. 33:313-317.
358. Roilides, E., K. M. Butler, R. N. Husson, B. V. Mueller, L. L. Lewis, and P. A. Pizzo. 1992. Pseudomonas infections in children with HIV infection. Pediatr. Infect. Dis. J. 11:547-553.
359. Kolston, K. V. I., E. A. Anaissie, and G. P. Bodey. 1987. In vitro susceptibility of Pseudomonas species to fifteen antimicrobial agents. J. Antimicrob. Chemother. 19:193-196.
360. Rolston, K. V. I, D. H. Ho, B. LeBlanc, H. Streeter, and T. Dvorak. 1997. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer. J. Antimicrob. Chemother. 39(Suppl. B):15-22.
361. Rolston, K. V. I., M. Messer, and D. H. Ho. 1990. Comparative in vitro activities of newer quinolones against Pseudomonas species and Xanthomonas maltophilia isolated from patients with cancer. Antimicrob. Agents Chemother. 34:1812-1813.
362. Rosenblatt, J. E., and P. R. Stewart. 1974. Combined activity of sulfamethoxazole, trimethoprim and polymyxin B against gram-negative bacilli. Antimicrob. Agents Chemother. 6:84-92.
363. Rosenthal, S. L. 1974. Sources of Pseudomonas and Acinetobacter species found in human culture. Am. J. Clin. Pathol. 62:807-811.
364. Rosta, S., and H. Mett. 1989. Physiological studies of the regulation of β-lactamase expression in Pseudomonas maltophilia. J. Bacteriol. 171:483-487.
365. Roupas, A., J. S. Pitton, and F. A. Waldvogel. 1973. Influence de la temperature sur l'activite de la gentamycine chez Pseudomonas maltophilia. Schweiz. Rundsch. Med. Prax. 62:436-440.
366. Rouse, M. S., B. M. Tallan, N. K. Henry, J. M. Steckelberg, and W. R. Wilson. 1991. Treatment of Xanthomonas maltophilia experimental pneumonia. Chest 12(Suppl.):147S.
367. Sader, H. S., and R. N. Jones. 1993. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad spectrum beta-lactam drugs. Eur. J. Clin. Microbiol. Infect. Dis. 12:384-391.
368. Sader, H. S., R. N. Jones, S. D. Allen, E. H. Gerlach, P. R. Murray, and J. A. Washington. 1993. In vitro comparison of activity of PC-17116, a new fluoroquinolone against more than 5000 recent clinical isolates from five medical centers. J. Chemother. 5:283-288.
369. Sader, H. S., A. C. Pignatari, R. Frei, R. J. Hollis, and R. N. Jones. 1994. Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland, and the USA. J. Antimicrob. Chemother. 33:615-618.
370. Saino, Y., M. Inoue, and S. Mitsubishi. 1984. Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrob. Agents Chemother. 25:362-365.
371. Saino, Y., F. Kobayashi, M. Inoue, and S. Mitsuhashi. 1982. Purification and properties of inducible penicillin β-lactamase isolated from Pseudomonas maltophilia. Antimicrob. Agents Chemother. 22:564-570.
372. Sarkar, T. K., G. Gilardi, A. S. Aguam, J. Josephson, and G. Leventhal. 1979. Primary Pseudomonas maltophilia infection of the lung. Postgrad. Med. 65:253-256, 260.
373. Sarvamangala-Devi, J. N., A. Venkatesh, and P. G. Shivanandra. 1984. Neonatal infections due to Pseudomonas maltophilia. Indian Pediatr. 21: 72-73.
374. Schable, B., D. L. Rhoden, R. Hugh, R. E. Weaver, N. Khardori, P. B. Smith, G. P. Bodey, and R. L. Anderson. 1989. Serological classification of Xanthomonas maltophilia (Pseudomonas maltophilia) based on heat-stable O antigens. J. Clin. Microbiol. 27:1011-1014.
375. Schable, B., D. L. Rhoden, W. R. Jarvis, and J. M. Miller. 1992. Prevalence of serotypes of Xanthomonas maltophilia from worldwide sources. Epidemiol. Infect. 108:337-341.
376. Schable, B., M. E. Villarino, M. S. Favero, and J. M. Miller. 1991. Application of multilocus enzyme electrophoresis to epidemiologic investigations of Xanthomonas maltophilia. Infect. Control Hosp. Epidemiol. 12:163-167.
377. Scharmann, W. 1972. Vorkommen von elatase bei Pseudomonas und Aeromonas. Zentralbl. Bakteriol. Microbiol. Hyg. 1 Abt. Orig. A 220:435-442.
378. Semel, J. D., G. M. Trenholme, A. A. Harris, J. E. Jupa, and S. Levin. 1978. Pseudomonas maltophilia pseudosepticaemia. Am. J. Med. 64:403-406.
379. Sequeira, W., E. Jones, M. E. Siegel, M. Lorenz, and C. Kallick. 1982. Pyogenic infections of the symphysis pubis. Ann. Intern. Med. 96:604-606.
380. Shen, P., M. Huang, and Z. Peng. 1992. Studies of plasmids of Pseudomonas maltophilia. Acta Genet. Sin. 19:355-361.
381. Sierra, M., M. L. Garcia-Lopez, E. Gonzalez, M. C. Garcia, and O. Otero. 1995. Species of psychrotrophic bacteria on freshly-dressed Iamb carcasses. Arch. Lebensmittelhyg. 46:20, 22-23.
382. Sikorowski, P. P., J. E. Powell, and A. M. Lawrence. 1992. Effects of bacterial contamination on development of Micropolitis croceipes. Entomophaga 37:475-481.
383. Singer, E., J. Debette, A. Lepretre, and J. Swings. 1994. Comparative esterase electrophoretic polymorphism and phenotypic analysis of Xanthomonas maltophilia and related strains. Syst. Appl. Microbiol. 17:387-394.
384. Smit, W. J., A. L. Boquest, J. E. Geddes, and F. A. Tosolini. 1994. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management. Pathology 26:321-324.
385. Smith, S. M., K. R. Cundy, G. L. Gilardi, and W. Wang. 1982. Evaluation of the AutoMicrobic system for identification of glucose-nonfermenting gram-negative rods. J. Clin. Microbiol. 15:302-307.
386. Snyder, M. E., and H. R. Katz. 1992. Ciprofloxacin-resistant bacterial keratitis. Am. J. Ophthalmol. 114:336-338.
387. Sogaard, P., B. Gahrn-Hansen, Z. Hui-Ping, and W. Frederiksen, 1986. An investigation of three commercial methods for rapid identification of nonenteric gram-negative rods. Acta. Pathol. Microbiol. Immunol. Scand. Sect. B 94:357-363.
388. Sonnenwirth, A. C. 1970. Bacteremia with and without meningitis due to Yersinia enterocolitica, Edwardsiella tarda, Comamonas terrigena, and Pseudomonas maltophilia. Ann. N. Y, Acad. Sci. 174:488-502.
389. Soriano, V., E. Valencia, A. Alba, and J. Gonzalez-Lahoz. 1994. Endocarditis por Xanthomonas maltophilia en un paciente con SIDA. Med. Clin. 102:399.
390. Southern, P. M., Jr., and M. L. Schneider. 1974. Pseudomonas maltophilia in clinical bacteriologic specimens. Texas Rep. Biol. Med. 32:880.
391. Spangler, S. K., M. A. Visalli, M. R. Jacobs, and P. C. Applebaum. 1996. Susceptibilities of non-Pseudomonas aeruginosa gram-negative non-fermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. Antimicrob. Agents Chemother. 40:772-775.
392. Spencer, R. C. 1995. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J. Hosp. Infect. 30(Suppl.):453-464.
393. Spraul, C. W., G. E. Lang, and G. K. Lang. 1996. Xanthomonas maltophilia keratitis associated with contact lenses. CLAO J. 22:158.
394. Staneck, J. L., L. S. Weckbach, R. C. Tilton, R. J. Zabransky, L. Bayola-Mueller, C. M. O'Hara, and J. M. Miller. 1993. Collaborative evaluation of the Radiometer Sensititre AP80 for identification of gram-negative bacilli. J. Clin. Microbiol. 31:1179-1184.
395. Stanier, R. Y., N. J. Palleroni, and M. Doudoroff. 1966. The aerobic pseudomonads: a taxonomic study. J. Gen. Microbiol. 43:159-271.
396. Stevens, C. M., D. Swaine, C. Butler, A. H. Carr, A. Weightman, C. R. Catchpole, D. E. Healing, and T. S. J. Elliott. 1994. Development of o.a.s.i.s., a new automated blood culture system in which detection is based on measurement of bottle headspace pressure changes. J. Clin. Microbiol. 32:1750-1756.
397. Strandberg, D. A., J. H. Jorgensen, and D. J. Drutz. 1983. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob. Agents Chemother. 24:282-286.
398. Su, J. J., and D. Kafkewitz. 1994. Utilization of toluene and xylenes by a nitrate-reducing strain of Pseudomonas maltophilia under low oxygen and anoxic conditions. FEMS Microbiol. Ecol. 15:249-257.
399. Subbannayya, K., K. Ramnarayan, P. G. Shivananda, P. Shatapathy, and P. Mathai. 1984. Pseudomonas maltophilia endocarditis. Indian J. Pathol. Microbiol. 27:311-315.
400. Suga, K., T. Kabashima, K. Ito, D. Tsuru, H. Okamura, J. Kataoka, and T. Yoshimoto. 1995. Prolidase from Xanthomonas maltophilia: purification and characterization of the enzyme. Biosci. Biotechnol. Biochem. 59:2087-2090.
401. Sutter, V. L. 1968. Identification of Pseudomonas species isolated from hospital environment and human sources. Appl. Microbiol. 16:1532-1538.
402. Swings, J., P. De Vos, M. Van den Mooter, and J. De Ley. 1983. Transfer of Pseudomonas maltophilia Hugh 1981 to the genus Xanthomonas as Xanthomonas maltophilia (Hugh 1981) comb. nov. Int. J. Syst. Bacteriol. 33: 409-413.
403. Szeto, C. C., P. K. Li, C. B. Leung, A. W. Yu, S. F. Lui, and K. N. Lai. 1997. Xanthomonas maltophilia peritonitis in uremic patients receiving continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis. 29:91-95.
404. Taber, T. E., T. F. Hegeman, S. M. York, R. A. Kinney, and D. H. Webb. 1991. Treatment at Pseudomonas infections in peritoneal dialysis patients. Periton. Dial. Int. 11:213-216.
405. Talon, D., P. Bailly, R. Leprat, C. Godard, E. Deconnink, J.-Y. Cahn, and Y. Michel-Briand. 1994. Typing of hospital strains of Xanthomonas maltophilia by pulsed-field gel electrophoresis. J. Hosp. Infect. 27:209-217.
406. Tanaka, M., M. Hohmura, T. Nishi, K. Sato, and H. Hayakawa. 1997. Antimicrobial activity of DU-6681a, a parent compound of the novel carbapenem DZ-2640. Antimicrob. Agents Chemother. 41:1260-1268.
407. Tenover, F. C., T. S. Mizuki, and L. G. Carlson. 1990. Evaluation of autoSCAN-W/A automated microbiology system for the identification of non-glucose-fermenting gram-negative bacilli. J. Clin. Microbiol. 28:1628-1634.
408. Tilton, R. C., O. Steingrimsson, and R. W. Ryan. 1978. Susceptibilities of Pseudomonas species to tetracycline, minocycline, gentamicin, and tobramycin. Am. J. Clin. Pathol. 69:410-413.
409. Todd, N. J., K. G. Kerr, M. Denton, and P. M. Hawkey. 1992. Extracellular enzyme activity of clinical and environmental strains of Xanthomonas maltophilia, abstr. L18. In Abstracts of the 92nd General Meeting of the American Society for Microbiology 1992. American Society for Microbiology, Washington, D.C.
410. Toledo-Pereyra, L. H., L. Raij, R. L. Simmons, and J. S. Najarian. 1974. Role of endotoxin and bacteria in long term survival of preserved small bowel allografts. Surgery 73:474-481.
411. Torres, A., R. Aznar, J. M. Gateil, P. Jimenez, J. Gonzalez, A. Ferrer, R. Celis, and R. Rodriguez-Roisin. 1990. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am. Rev. Respir. Dis. 142:523-528.
412. Townsend, R., T. G. Winstanley, and R. C. Spencer. 1991. In vitro susceptibility of Xanthomonas maltophilia to aztreonam and clavulanic acid as a test for the presumptive identification of the species. J. Hosp. Infect. 18: 324-325.
413. Traub, W. H., and M. Spohr. 1987. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia. Chemotherapy 33:340-346.
414. Trumbore, D., R. Pontzer, M. E. Levinson, D. Kaye, M. Cynamon, C. Liu, D. R. Hinthorn, J. S. Tan, and T. M. File. 1985. Multicenter study of the clinical efficiency of imipenem/cilastatin for treatment of serious infections. Rev. Infect. Dis. 7(Suppl. 3):S476-S480.
415. Trump, D. L., S. A. Grossman, G. Thompson, and K. Murray. 1982. CSF infections complicating the management of neoplastic meningitis: clinical features and results of therapy. Arch. Intern. Med. 142:583-586.
416. Turner-Hubbard, K., W. K. Hadley, J. L. Gerberding, H. F. Chambers, and F. Perdreau-Remington. 1996. Bronchoscope sterilization failure causing contamination of bronchoalveolar lavage with Xanthomonas (Stenotrophomonas) maltophilia. Infect. Control Hosp. Epidemiol. 17(Suppl.):P43.
417. Tyler, S. D., C. A. Strathdee, K. R. Rozee, and W. M. Johnson. 1995. Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of sequencing of genes coding for 16S-22S rRNA internal transcribed spacers. Clin. Diagn. Lab. Immunol. 2:448-453.
418. Ulrich, J. A., and G. M. Needham. 1953. Differentiation of Alcaligenes faecalis from Bordetella bronchisepticus [sic] by biochemical and nutritional methods. J. Bacteriol. 65:210-215.
419. Van Couwenberghe, C., and S. Cohen. 1994. Analysis of epidemic and endemic isolates of Xanthomonas maltophilia by contour clamped homogeneous electric field gel electrophoresis. Infect. Control Hosp. Epidemiol. 15:691-696.
420. Van Couwenberghe, C. J., S. H. Cohen, Y. J. Tang, P. H. Gumerlock, and J. Silva, Jr. 1995. Genomic fingerprinting of epidemic and endemic strains of Stenotrophomonas maltophilia (formerly Xanthomonas maltophilia) by arbitrarily primed PCR. J. Clin. Microbiol. 33:1289-1291.
421. Van den Mooter, M., and J. Swings. 1990. Numerical analysis of 295 phenotypic features of 266 Xanthomonas strains and related strains and an improved taxonomy of the genus. Int. J. Syst. Bacteriol. 40:348-369.
422. Vanholder, R., E. Vanhaecke, and S. Ringoir. 1992. Pseudomonas septicemia due to deficient disinfectant mixing during reuse. Int. J. Artific. Org. 15:19-24.
423. Vanhoof, R., P. Sonck, and E. Hannecart-Pokorni. 1995. The role of lipopolysaccharide anionic binding sites in aminoglycoside uptake in Stenotrophomonas (Xanthomonas) maltophilia. J. Antimicrob. Chcmother. 35:167-171.
424. Van Zyl, E., and P. L. Steyn. 1990. Differentiation of phytopathogenic Pseudomonas and Xanthomonas species and pathovars by numerical taxonomy and protein gel electrophoresis. Syst. Appl. Microbiol. 13:60-71.
425. Van Zyl, E., and P. L. Steyn. 1992. Reinterpretation of the taxonomic position of Xanthomonas maltophilia and taxonomic criteria in this genus. Request for an opinion. Int. J. Syst. Bacteriol. 42:193-198.
426. Varettas, K., C. Mukerjee, and M. Schmidt. 1996. A comparative study of the BBL Crystal Enteric/Nonfermenter identification system and the Bio-Merieux API 20E and API 20NE identification systems after overnight incubation. Pathology 27:358-361.
427. Vartivarian, S., E. Anaissie, G. Bodey, H. Sprigg, and K. Rolston. 1994. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob. Agents Chemother. 38:624-627.
428. Vartivarian, S. E., K. A. Papadakis, and E. J. Anaissie. 1996. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. Arch. Intern. Med. 156:433-135.
429. Vartivarian, S. E., K. A. Papadakis, J. A. Palacios, J. T. Manning, and E. J. Anaissie. 1994. Mucocutaneous and soft tissue infections caused by Xanthomonas maltophilia: a new spectrum. Arch. Intern. Med. 121:969-973.
430. Vazquez, S. C., L. N. R. Merino, W. P. MacCormack, and E. R. Fraile. 1995. Protease-producing psychrotrophic bacteria isolated from Antarctica. Polar Biol. 15:131-135.
431. Veys, A., W. Callewaert, E. Waelkens, and K. van den Abbele. 1989. Application of gas-liquid chromatography to the routine identification of nonfermenting gram-negative bacteria in clinical specimens. J. Clin. Microbiol. 27:1538-1542.
432. Victor, M. A., M. Arpi, B. Bruun, V. Jonsson, and M. M. Hansen. 1994. Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand. J. Infect. Dis. 26:163-170.
433. Villarino, M. E., L. E. Stevens, B. Schable, G. Mayers, J. M. Miller, J. P. Burke, and W. R. Jarvis. 1992. Risk factors for epidemic Xanthomonas maltophilia infection/colonisation in intensive care unit patients. Infect. Control Hosp. Epidemiol. 13:201-206.
434. Visalli, M., S. Bajaksouzian, M. Jacobs, and P. Appelbaum. 1996. Activity of trovafloxacin alone and combined with ceftazidime, imipenem and amikacin against gram-negative nonfermenters, p. E86. In Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
435. Visser, M. R., L. Bogaards, M. Rozenberg-Arska, and J. Verhoef. 1992. Comparison of the autoSCAN-W/A and Vitek AutoMicrobic systems for identification and susceptibility testing of bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 11:979-984.
436. Von Graevenitz, A., and C. Bucher. 1983. Isolation of Pseudomonas maltophilia from human stools with thienamycin. Zentralbl. Bakteriol. Mikrobiol. Hyg. I Abt. Orig. A 254:403-404.
437. Vu-Thein, H., D. Moissenet, M. Valcin, C. Dulot, G. Tournier, and A. Garberg-Chenon. 1996. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur. J. Clin. Microbiol. Infect. Dis. 15:876-878.
438. Wagn, P., H. M. Hansen, P. S. Duun, and H. J. Kolmos. 1994. Xanthomonas maltophilia arsag til epidural absces has en patient med epiduralkateter. Ugeskr. Laeg. 156:7229-7230.
439. Walsh, T. R., L. Hall, S. J. Assinder, W. W. Nichols, S. J. Cartwright, A. P. MacGowan, and P. M. Bennett. 1994. Sequence analysis of the L1 metallobeta-lactamase from Xanthomonas maltophilia. Biochim. Biophys. Acta 1218:199-201.
440. Walsh, T. R., A. P. MacGowan, and P. M. Bennett. 1996. Sequence analysis of the L2 serine β-lactamase from Stenotrophomonas maltophilia, abstr. C33. In Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
441. Wauters, G., A. Boel, G. P. Voorn, J. Verhaegen, F. Meunier, M. Janssens, and L. Verbist. 1995. Evaluation of a new identification system. Crystal Enteric/Non-Fermenter, for gram-negative bacilli. J. Clin. Microbiol. 33: 845-849.
442. Wheat, P. F., T. G. Winstanley, and R. C. Spencer. 1985. Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia. J. Clin. Pathol. 38:1055-1058.
443. Whorwell, P. J., I. W. Davidson, W. L. Beeken, and R. Wright. 1978. Search by immunofluorescence for antigens of rotavirus, Pseudomonas maltophilia, and Mycobacterium kansasii in Crohn's disease. Lancet ii:697-698.
444. Whorwell, P. J., J. Graham, D. Machin, and R. Wright. 1981. Lymphocyte transformation to specific antigens associated with Crohn's disease. Hepato-Gastroenterol. 28:258-260.
445. Widjojoatmodjo, M. N., A. C. Fluit, and J. Verhoef. 1994. Rapid identification of bacteria by PCR-single strand conformation polymorphism. J. Clin. Microbiol. 32:3002-3007.
446. Wilcox, M. H., T. G. Winstanley, and R. C. Spencer. 1994. Outer membrane protein profiles of Xanthomonas maltophilia isolates displaying temperature-dependent susceptibility to gentamicin. J. Antimicrob. Chemother. 33:663-666.
447. Wilkinson, K. G., K. W. Dixon, K, Sivasithamparam, and E. L. Ghisalberti. 1994. Effect of IAA on symbiotic germination of an Australian orchid and its production by orchid associated bacteria. Plant Soil. 159:1291-1295.
448. Wilkinson, S. G., L. Galbraith, and W. J. Anderton. 1983. Lipopolysaccharides from Pseudomonas maltophilia: composition of the lipopolysaccharide and structure of the side-chain polysaccharide from strain N.C.I.B. 9204. Carbohydr. Res. 112:241-252.
449. Winn, A. M., L. Galbraith, G. S. Temple, and S. G. Wilkinson. 1993. Structure of the O19 antigen of Xanthomonas maltophilia. Carbohydr. Res. 247:249-254.
450. Winn, A. M., C. T. Miles, and S. G. Wilkinson. 1996. Structure of the O3 antigen of Stenotrophomonas (Xanthomonas) maltophilia. Carbohydr. Res. 282:149-156.
451. Winn, A. M., A. W. Miller, and S. G. Wilkinson. 1995. Structure of the O10 antigen of Stenotrophomonas (Xanthomonas) maltophilia. Carbohydr. Res. 267:127-133.
452. Winn, A. M., and S. G. Wilkinson. 1995. Structure of the O6 antigen of Stenotrophomonas (Xanthomonas or Pseudomonas) maltophilia. Carbohydr. Res. 272:225-230.
453. Winston, D. J., W. G. Ho, D. A. Bruckner, and R. E. Champlin. 1991. Beta-lactam therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Ann. Intern. Med. 115:849-859.
454. Wise, R., J. M. Andrews, and N. Brenwald. 1996. In vitro activity of the tricyclic β-lactam GV104326. Antimicrob. Agents Chemother. 40:1248-1253.
455. Wishart, M. M., and T. V. Riley. 1976. Infection with Pseudomonas maltophilia: hospital outbreak due to contaminated disinfectant. Med. J. Aust. 2:710-712.
456. Witchitz, S., B. Regnier, J. Witchitz, B. Schlemmer, E. Bouvet, and F. Vachan. 1982. Les endocardites a bacilles gram negatif. Pathol, Biol. 30: 569-575.
457. Wood, M. E., and A. C. Newland. 1986. Intravenous ciprofloxacin in the treatment of infection in immunocompromised patients. J. Antimicrob. Chemother. 18(Suppl. D):175-178.
458. Wust, J., R. Frei, H. Gunthard, and M. Altwegg. 1995. Analysis of restriction fragment length polymorphism and ribotyping of multiresistant Stenotrophomonas maltophilia isolated from persisting lung infection in a cystic fibrosis patient. Scand. J. Infect. Dis. 27:499-502.
459. Yamazaki, E., J. Ishii, K. Sato, and T. Nakae. 1989. The barrier function of the outer membrane of Pseudomonas maltophilia in the diffusion of saccharides and beta-lactam antibiotics. FEMS Microbiol. Lett. 60:85-88.
460. Yang, P., L. Vauterin, M. Vancanneyt, J. Swings, and K. Kersters. 1993. Application of fatty acid methyl esters for the taxonomic analysis of the genus Xanthomonas. Syst. Appl. Microbiol. 16:47-71.
461. Yang, P., P. de Vos, K. Kersters, and J. Swings. 1993. Polyamine patterns as chemotaxonomic markers for the genus Xanthomonas maltophilia. Int. J. Syst. Bacteriol. 43:709-714.
462. Yao, J. D. C., J. M. Conly, and M. Krajden. 1995. Molecular typing of Stenotrophomonas (Xanthomonas) maltophilia by DNA macrorestriction analysis and random amplified polymorphic DNA analysis. J. Clin. Microbiol. 33:2195-2198.
463. Yao, J. D. C., M. Louie, L. Louie, J. Goodfellow, and A. E. Simor. 1995. Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia. J. Clin. Microbiol. 33:1428-1430.
464. Yeh, T. J., I. N. Anabtawi, V. E. Cornett, A. White, W. H. Stern, and R. G. Ellison. 1967. Bacterial endocarditis following open heart surgery. Ann. Thorac. Surg. 3:29-36.
465. Yousem, S. A. 1992. Graft eosinophilia in lung transplantation. Hum. Pathol. 23:1172-1177.
466. Yu, V. L., T. P. Felegie, R. B. Yee, A. W. Pasculle, and F. H. Taylor. 1980. Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. J. Infect. Dis. 142:602-607.
467. Yu, V. L., L. W. Rumans, E. J. Wing, R. McLeod, F. N. Sattler, R. M. Harvey, and S. C. Deresinski. 1978. Pseudomonas maltophilia causing heroin-associated infective endocarditis. Arch. Intern. Med. 138:1667-1671.
468. Zechman, J. M., and J. N. Labows. 1985. Volatiles of Pseudomonas aeruginosa and related species by automated headspace concentration gas chromatography. Can. J. Microbiol. 31:232-237.
469. Zhong, W. P. 1990. Identification and classification of 204 strains of gram-negative organisms isolated from poultry eggs. Chin. J. Prev. Med. 24:257-260. (In Chinese.)
470. Zuravleff, J. J., and V. L. Yu. 1982. Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and review of the literature. Rev. Infect. Dis. 4:1236-1246.